gujarat technological university student list for m.pharm ... · 40 23-jul-20 hall 06 182060824007...

Exam Time :- 10:45 AM ONWARDS

Sr.No DATE HALL MAP_NUMBER Student Name subject codeBranch_

Code

College_

Code

Branch_T

ypeBranch_name Micro Other_Micro ITD_TITLE GName

1 23-Jul-20 Hall 01 182060820002PANCHAL KUNAL PRAKASHCHANDRA (NON

PGCET)MRW404P 20 206 MP Pharmaceutics

BUCO/MUCOADHESIVE, TDDS,

TOPICAL, HYDROGELS NASAL

FORMULATION AND EVALUATION OF SUSTAINED

RELEASE BUCCAL TABLETS OF ZOLPIDEM TARTRATEDR.MITTAL MAHESHWARI

2 23-Jul-20 Hall 01 182060820004 Vekariya pareshkumar jagdishbhai MRW404P 20 206 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF

GASTRORETENTIVE MUCOADHESIVE TABLETS OF

KETOROLAC TROMETHAMINE

DR. MITTAL

MAHESHWARI

3 23-Jul-20 Hall 01 182080820003 PANDYA ARTH JAYESH MRW404P 20 208 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVI


ACETAMINOPHEN MOUTH DISSOLVING TABLET.DR. HIRAL SHAH

4 23-Jul-20 Hall 01 182080820004 PANDYA SHIVANI SHAILESHBHAI MRW404P 20 208 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COMPRESSION-

COATED PULSATILE RELEASE TABLET OF ETODOLAC

FOR RHEUMATOID ARTHRITIS.

DR. UPENDRA L. PATEL

5 23-Jul-20 Hall 01 182080820005 PATEL AKASH BHAVDEEPBHAI MRW404P 20 208 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF IMMEDIATE

RELEASE OF SILDENAFIL AND FLUOXETINEMR. BHAVIN BHIMANI

6 23-Jul-20 Hall 01 182080820008 PATEL HIRANGI KIRTIKUMAR MRW404P 20 208 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF MICROSPHERES

BASED TOPICAL GEL OF APREMILAST.DR. HIRAL SHAH

7 23-Jul-20 Hall 01 182280820007 SHAH ANOKHI MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DESIGN, DEVELOPMENT AND EVALUATION OF

SUBLINGUAL FILMS CONTAINING DARIFENACIN

HYDROBROMIDE

DR. PRAFUL D. BHARADIA

8 23-Jul-20 Hall 01 152240808011 Patel Rakeshkumar Arvindbhai 940102 08 224 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


RELEASE TABLETS OF CARVEDILOL PHOSPHATEMR. JAYANTI BAJAG

9 23-Jul-20 Hall 02 182240820001 Parmar Gaurangkumar Pankajbhai MRW404P 20 224 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF IMMEDIATE

RELEASE TABLETS OF EMPAGLIFLOZINMRS SEJAL M SOLANKI

10 23-Jul-20 Hall 02 182240820002 Patel Nihalkumar Mukeshbhai MRW404P 20 224 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


RELEASE MATRIX TABLETS OF RIVAROXABANMR JAYANTI V BAJAG

11 23-Jul-20 Hall 02 182280820001 ANKIT KOUL MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION DEVELOPMENT AND EVALUATION OF

SUBLINGUAL TABLETS OF APIXABANDR. PRAFUL D. BHARADIA

12 23-Jul-20 Hall 02 182280820008 SHAH STUTEE NIMESHBHAI MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION, OPTIMIZATION AND EVALUATION OF

SUBLINGUAL FILMS OF OLMESARTAN MEDOXOMILDR. PRAFUL D. BHARADIA

13 23-Jul-20 Hall 02 182280820009 Shah Vatsal Rakeshbhai MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL

TABLETS OF RUPATADINE FUMARATEDR. YAMINI D. SHAH

14 23-Jul-20 Hall 02 182280820010 vachheta dolly nareshbhai MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



TABLETS OF OXYBUTYNIN CHLORIDEDR. YAMINI D. SHAH

15 23-Jul-20 Hall 02 182600820001 GODHA JIGAR GUNVANTBHAI MRW404P 20 260 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF FILM COATED

IMMEDIATE RELEASE TABLETS OF BISOPROLOL

FUMARATE

MR. HARSH J. TRIVEDI

16 23-Jul-20 Hall 02 172424820001 BHAKHOTRA RUPABEN JADAVBHAI MRW403P 20 264 MP PharmaceuticsFormulation and Evaluation of Mouth Dissolving

Film of Zolpidem Tartrate DR. DHAVAL J. PATEL

17 23-Jul-20 Hall 03 182280820002 JETHA KESHAVA LAKSHMINARAYAN MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



ORAL TRANS-MUCOSAL DELIVERY SYSTEM OF

ALFUZOSIN HYDROCHLORIDE FOR TREATMENT OF

BENIGN PROSTATIC HYPERPLASIA.

DR. PRAFUL D. BHARADIA

18 23-Jul-20 Hall 03 182280820003 MAKWANA BRINDA RATNASINH MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



ORAL TRANSMUCOSAL DELIVERY SYSTEM OF

AMITRIPTYLINE HYDROCHLORIDE

DR. RADHIKA B. PANDYA

Student list for M.Pharm Sem 4 (Regular) Dissertation Phase-II Exam (Summer 2020)GTU/S20/DP-II/MPH-3225/5020 Date:- 14/07/2020

Gujarat Technological University

of 27



Code

College_

Code

Branch_T




19 23-Jul-20 Hall 03 182280820004 PATEL NIDHI HARSHADBHAI MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLETS OF NADOLOLDR. MANISH P. PATEL

20 23-Jul-20 Hall 03 182280820005 PRAJAPATI HIMALI JAYENDRABHAI MRW404P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



RAPID MOUTH DISSOLVING TABLETS OF FIMASARTAN

POTASSIUM TRIHYDRATE

DR. MANISH P. PATEL

21 23-Jul-20 Hall 03 182420820002 MODI JAYKUMAR KAMLESHBHAI MRW404P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND CHARACTERISATION OF

CHLORTHALIDONE LIQUISOLID COMPACTSDR S K SHAH

22 23-Jul-20 Hall 03 182420820003 PATEL SURESHBHAI KUBERBHAI MRW404P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF STABLE NON-

AQUEOUS SOLUTION OF DOXYCYCLINE HYCLATE.DR DHAVAL J PATEL

23 23-Jul-20 Hall 03 182420820005 SHAH RAHUL VINAYKUMAR MRW404P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF OXYBUTYNIN

CHLORIDE OSMOTICALLY CONTROLLED RELEASE

TABLETS.

DR DHAVAL J PATEL

24 23-Jul-20 Hall 03 182420820006 SHAH RAJ NITINKUMAR MRW404P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


GASTRORETENTIVE FLOATING TABLETS OF

FEBUXOSTAT

DR S K SHAH

25 23-Jul-20 Hall 04 182420820008 SHUKLA BHRANTI BHASKARBHAI MRW404P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERIZATION AND

DISSOLUTION ENHANCEMENT OF MACITENTAN BY

SOLID DISPERSION TECHNIQUE

DR DHAVAL J PATEL

26 23-Jul-20 Hall 04 182420820009 YADAV POONAM SURESHBHAI MRW404P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF STOMACH

SPECIFIC FLOATING TABLETS OF ELUXADOLINE.DR SANJESH G. RATHI

27 23-Jul-20 Hall 04 182420820010 ZALA SEJALKUMARI ARJUNSINH MRW404P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SPHERICAL

CRYSTAL AGGLOMERATES OF LURASIDONE

HYDROCHLORIDE.

DR SANJESH G RATHI

28 23-Jul-20 Hall 04 182620820001 ANSARI GAZALA MOHAMMEDYUSUFBHAI MRW404P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


SOLUBILITY ENHANCEMENT OF PALIPERIDONE HCL BY

SOLID DISPERSION METHODMR. SURAJ R. CHAUHAN

29 23-Jul-20 Hall 04 182620820002 JAT MANJITSINGH NANURAM MRW404P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND CHARACTERIZATION OF

SUSTAINED MATRIX TABLETS OF VILDAGLIPTINPROF. RAVI V. PATEL

30 23-Jul-20 Hall 04 182620820003 QURESHI NADEEM NAJIRMAHAMMAD MRW404P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORAL

DISINTEGRATING FILM OF SITAGLIPTIN PHOSPHATEMS. BHUMI A. RAVAL

31 23-Jul-20 Hall 04 182620820004 VASOYA VISHALBHAI BHARATBHAI MRW404P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



FILM OF IVABRADINE HCLPROF. RAVI V. PATEL

32 23-Jul-20 Hall 05 182080820001 BHATT KAUSHIKKUMAR JAYANTKUMAR MRW404P 20 208 MP Pharmaceutics OTHER (KINDLY SPECIFY) LOZENGES

FORMULATION AND EVALUATION OF MEDICATED

LOZENGES OF TRIAMCINOLONE ACETONIDE WITH

SOLUBILITY ENHANCEMENT

MR. GHANSHYAM PATEL

33 23-Jul-20 Hall 05 182080820006 PATEL DHWANIBAHEN ARVINDBHAI MRW404P 20 208 MP PharmaceuticsVESICULAR DRUG DELIVERY

SYSTEM

NANOEMULSION BASED NOSE TO BRAIN DELIVERY OF

DOLUTEGRAVIR.DR. SUNITA CHAUDHARY

34 23-Jul-20 Hall 05 182080820007 PATEL DRASHTI INDRAVADANBHAI MRW404P 20 208 MP PharmaceuticsVESICULAR DRUG DELIVERY

SYSTEM

PREPARATION AND CHARACTERIZATION OF

DEXIBUPROFEN SUSPENSION FOR INTRAMUSCULAR

DEPOT THERAPY.

DR. UPENDRA L. PATEL

35 23-Jul-20 Hall 05 182080820009 SHARMA ASHUTOSH MUNESHCHANDRA MRW404P 20 208 MP Pharmaceutics OTHER (KINDLY SPECIFY) TEST MASKINGFORMULATION AND EVALUATION OF TASTE MASKED

DRY SYRUP OF CEFUROXIME AXETIL.DR. SUNITA CHAUDHARY

36 23-Jul-20 Hall 05 182280820006 RUPANI HETANSH PARESHBHAI MRW404P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)DISSOLUTION

ENHANCEMENT

DISSOLUTION ENHANCEMENT OF BILASTINE USING

DIFFERENT TECHNIQUES.DR. MANISH P. PATEL

37 23-Jul-20 Hall 05 182600820003 KATHIRIYA BHAGAVATIBEN VIPULBHAI MRW404P 20 260 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN AND EVALUATION OF ONCE DAILY EXTENDED

RELEASE TABLETS OF ANTIEPILEPTIC DRUGDR. KUNAL N. PATEL

38 23-Jul-20 Hall 05 182600820006 YADAV VIPIN THANSINGH MRW404P 20 260 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


NATURAL POLYMER BASED TABLETS FOR EXTENDED

RELEASE OF FLUVOXAMINE MALEATE

MRS. BHAVANA A. PATEL

of 27



Code

College_

Code

Branch_T




39 23-Jul-20 Hall 06 182060824002 Patel Nidhi Shaileshbhai MRW404P 24 206 MPPharmaceutical Quality

AssuranceSTABILITY STUDIES

ANALYTICAL METHOD DEVELOPMENT AND

VALIDATION OF STABILITY INDICATING RP-HPLC

METHOD FOR ESTIMATION OF DAPAGLIFLOZIN,

SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE IN

SYNTHETIC MIXTURE.

DR.NEHA TIWARI

40 23-Jul-20 Hall 06 182060824007 SHAH PRIYA MANISHKUMAR MRW404P 24 206 MPPharmaceutical Quality


STABILITY INDICATING RP-HPLC METHOD

DEVELOPMENT AND VALIDATION FOR FERRIC

MALTOL AND ITS PHARMACEUTICAL DOSAGE FORM

DR. PRAGNESH PATANI

41 23-Jul-20 Hall 06 182080824002 KOTHARI DHRUV HARIKRUSHNBHAI MRW404P 24 208 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF STABILITY

INDICATING HPTLC METHOD FOR SIMULTANEOUS

ESTIMATION OF AMLODIPINE BESYLATE AND

CELECOXIB IN TABLET DOSAGE FORM

DR JIGNASHA DERASARI

42 23-Jul-20 Hall 06 182080824005 PATEL HIMANIBEN MANISHBHAI MRW404P 24 208 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF NEFOPAM

HYDROCHLORIDE IN TABLET DOSAGE FORM

MS. MONA CHRISTIAN

43 23-Jul-20 Hall 06 182080824006 PATEL NIDHI DINESHKUMAR MRW404P 24 208 MPPharmaceutical Quality


IMPROVED STABILITY INDICATING RP-HPLC METHOD

DEVELOPMENT AND VALIDATION OF FEBUXOSTAT IN

TABLET DOSAGE FORM

MR. HIREN KADIKAR

44 23-Jul-20 Hall 06 182280824001 KATARIA JAHANVIBEN ANILKUMAR MRW404P 24 228 MPPharmaceutical Quality

AssuranceHERBAL

FORMULATION AND STANDARDIZATION OF A PHYTO-

PHARMACEUTICAL TABLET DOSAGE FORM

CONTAINING PIPER LONGUM

DR. JAYANT B. DAVE

45 23-Jul-20 Hall 06 182280824003 Panchal Bhoomi Ghanshyambhai MRW404P 24 228 MPPharmaceutical Quality

AssuranceOTHER (KINDLY SPECIFY) IMPURITY ANALYSIS

DEVELOPMENT AND VALIDATION OF LIQUID

CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS

DETERMINATION OF NITROSAMINE IMPURITIES IN

VALSARTAN

DR. KUNJAN BODIWALA

46 23-Jul-20 Hall 06 182280824005 PRAJAPATI PRITI KALPESH MRW404P 24 228 MPPharmaceutical Quality

AssuranceOTHER (KINDLY SPECIFY)

STABILITY

INDICATING ASSAY

METHOD

DEVELOPMENT AND VALIDATION OF UV

SPECTROPHOTOMETRIC AND STABILITY INDICATING

CHROMATOGRAPHIC METHODS FOR THE

ESTIMATION OF EVOGLIPTIN TARTRATE IN DOSAGE

FORMS

DR. ANURADHA K. GAJJAR

47 23-Jul-20 Hall 07 182080824010 SHAH JAINA VIPULBHAI MRW404P 24 208 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF AMINOCAPROIC

ACID IN PHARMACEUTICAL DOSAGE FORM

MR. HIREN KADIKAR

48 23-Jul-20 Hall 07 182080824012 SHAILY SANJAYKUMAR MODI MRW404P 24 208 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF ERTUGLIFLOZIN

IN PHARMACEUTICAL DOSAGE FORM

MS. MONA CHRISTIAN

49 23-Jul-20 Hall 07 182620824002CHANDALAWALA CHITRANGI

PARESHKUMARMRW404P 24 262 MP

Pharmaceutical Quality


STABILITY INDICATING ANALYTICAL METHOD

DEVELOPMENT AND VALIDATION FOR THE

SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND

PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

50 23-Jul-20 Hall 07 182620824004 LIMBACHIYA PARESHKUMAR BALDEVBHAI MRW404P 24 262 MPPharmaceutical Quality




SIMULTANEOUS ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND LISINOPRIL IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

51 23-Jul-20 Hall 07 182620824005 MISHRA SWETAKUMARI HARSHNATH MRW404P 24 262 MPPharmaceutical Quality




SIMULTANEOUS ESTIMATION OF LOSARTAN

POTASSIUM AND ROSUVASTATIN CALCIUM IN

SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

of 27



Code

College_

Code

Branch_T




52 23-Jul-20 Hall 07 182620824006 PADHERIYA MAITRI DILAVARSINGH MRW404P 24 262 MPPharmaceutical Quality




SIMULTANEOUS ESTIMATION OF LISINOPRIL AND

LOSARTAN POTASSIUM IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

53 23-Jul-20 Hall 07 182620824012 SABALPARA DIVYA JAYANTILAL MRW404P 24 262 MPPharmaceutical Quality




SIMULTANEOUS ESTIMATION OF VILDAGLIPTIN AND

PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

54 23-Jul-20 Hall 08 182080824001 AANCHAL JAIN MRW404P 24 208 MPPharmaceutical Quality


SYNTHESIS OF

BIOCONJUGATES

SYNTHESIS, CHARACTERIZATION AND SCREENING OF

NOVEL ANTIBIOTIC BIOCONJUGATESDR. NISHA PARIKH

55 23-Jul-20 Hall 08 182080824003 MIRAL DOSI MRW404P 24 208 MPPharmaceutical Quality

AssuranceSIMULTENEOUS ESTIMATION


VALIDATION OF CARGLUMIC ACID IN

PHARMACEUTICAL DOSAGE FORM

DR. NISHA PARIKH

56 23-Jul-20 Hall 08 182080824004 Patel foram pareshkumar MRW404P 24 208 MPPharmaceutical Quality


RP-HPLC METHOD DEVELOPMENT AND VALIDATION

OF SIMULTANEOUS ESTIMATION OF DORAVIRINE,

LAMIVUDINE AND TENOFOVIR DISPROXIL FUMARATE


DR. JITENDRA S PATEL

57 23-Jul-20 Hall 08 182080824007 PATEL SHIVANGINI ASHWINKUMAR MRW404P 24 208 MPPharmaceutical Quality


HPTLC METHOD DEVELOPMENT AND VALIDATION OF

CARICA PAPAYA L. LEAF EXTRACT IN TABLET DOSAGE

FORM

MS. MONA CHRISTIAN

58 23-Jul-20 Hall 08 182080824009 SHAH CHARMI DIPAKKUMAR MRW404P 24 208 MPPharmaceutical Quality

AssuranceIMPURITY PROFILING


VALIDATION OF APREMILAST AND ITS RELATED

SUBSTANCES IN TABLET DOSAGE FORM BY RP-HPLC

DR. JITENDRA PATEL

59 23-Jul-20 Hall 08 182080824011 Shah Rajvi Nikhil MRW404P 24 208 MPPharmaceutical Quality


IDENTIFICATION, SEPARATION, ISOLATION AND

CHARACTERIZATION OF POTENTIAL IMPURITY OF

EMPAGLIFLOZIN

DR. NISHA PARIKH

60 23-Jul-20 Hall 08 182620824001 BACHCHHAV SHWETA KAILASH MRW404P 24 262 MPPharmaceutical Quality


ANALYTICAL METHODS DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS ESTIMATION OF

DAPAGLIFLOZIN AND PIOGLITAZONE

HYDROCHLORIDE IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

61 23-Jul-20 Hall 08 182620824003 LIMANI GUNJAN NARENDRAKUMAR MRW404P 24 262 MPPharmaceutical Quality




SIMVASTATIN AND FENOFIBRATE IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

62 23-Jul-20 Hall 09 182080824008 SHAH AAYESHA ABHAYKUMAR MRW404P 24 208 MPPharmaceutical Quality


SYNTHESIS OF

STATIN

CONJUGATES

SYNTHESIS, CHARACTERIZATION AND

DETERMINATION OF PHYSICOCHEMICAL PROPERTIES

OF NOVEL STATIN CONJUGATES

DR. JIGNASHA DERASARI

63 23-Jul-20 Hall 09 182280824002NAVLIWALA MOHAMMADHASIL

ABDULSAMADMRW404P 24 228 MP

Pharmaceutical Quality


ANALYTICAL

METHOD

DEVELOPMENT AND

VALIDATION

DEVELOPMENT AND VALIDATION OF ANALYTICAL

METHOD FOR ESTIMATION OF REMOGLIFLOZIN

ETABONATE IN ITS TABLET DOSAGE FORMS

DR. DR. SINDHU B EZHAVA

64 23-Jul-20 Hall 09 182280824006 RANA PINAL MAHENDRAKUMAR MRW404P 24 228 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF HPLC METHOD

FOR ESTIMATION OF OFLOXACIN, TINIDAZOLE,

TERBINAFINE HYDROCHLORIDE AND CLOBETASOL

PROPIONATE IN TOPICAL FORMULATION

DR. KUNJAN BODIWALA

65 23-Jul-20 Hall 09 182280824007 SHETH PRACHI KETANKUMAR MRW404P 24 228 MPPharmaceutical Quality



VALIDATION FOR THE SIMULTANEOUS ESTIMATION

OF MOXIFLOXACIN HYDROCHLORIDE AND

LOTEPREDNOL ETABONATE IN OPHTHALMIC DOSAGE

FORM

DR. ANURADHA K. GAJJAR

of 27



Code

College_

Code

Branch_T




66 23-Jul-20 Hall 09 182280824008 SURI RUCHITA HARISHCHANDRA MRW404P 24 228 MPPharmaceutical Quality



METHOD FOR ESTIMATION OF METFORMIN

HYDROCHLORIDE, DAPAGLIFLOZIN PROPANEDIOL

AND SAXAGLIPTIN HYDROCHLORIDE IN BINARY FIXED

DOSE COMBINATION

DR. SINDHU EZHAVA

67 23-Jul-20 Hall 09 182620824008 Patel Hinal Chhotubhai MRW404P 24 262 MPPharmaceutical Quality


METHOD DEVELOPMENT AND VALIDATION OF

BETAMETHASONE SODIUM PHOSPHATE AND

BETAMETHASONE ACETATE IN PHARMACEUTICAL

DOSAGE FORM BY RP-HPLC METHOD

DR. JITENDRA O.

BHANGALE

68 23-Jul-20 Hall 09 182620824009 PATEL MRUGANK HEMENDRA MRW404P 24 262 MPPharmaceutical Quality




OCTREOTIDE ACETATE INJECTABLE SUSPENSION

DR. JITENDRA O.

BHANGALE

69 23-Jul-20 Hall 09 182620824013 SHAH RIYABEN PRAKASHKUMAR MRW404P 24 262 MPPharmaceutical Quality




FOSINOPRIL SODIUM AND PRAVASTATIN SODIUM IN

SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

70 24-Jul-20 Hall 01 182070820001 BHATT KRUTIBAHEN INDRAVADANBHAI MRW404P 20 207 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

PREPARATION AND EVALUATION OF

GASTRORETENTIVE IN-SITU GEL OF SUCRALFATE AND

OXETACAINE

DR ANAND K PATEL

71 24-Jul-20 Hall 01 182230828001 PATEL RIDDHIBEN RAMESHCHANDRA MRW404P 28 223 MPPharmaceutical

Technology

NANO SUSPENSION/EMULSION,

SEDDS, LIPID BASED DDS


NANOEMULSION FOR INTRANASAL DELIVERY OF

LURASIDONE HYDROCHLORIDE

DR. ALIASGAR J

KUNDAWALA

72 24-Jul-20 Hall 01 182420820007 SHARMA PANKAJKUMAR GORAKHNATH MRW404P 20 242 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT AND OPTIMIZATION OF

LOTEPREDNOL ETABONATE LOADED IN OPTHALMIC

NANOGEL

DR S K SHAH

73 24-Jul-20 Hall 01 182520820002 KADIYA PARTH DILIPKUMAR MRW404P 20 252 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE EXCIPIENTS AND

AT

DEVELOPMENT OF NEW MULTIPURPOSE DIRECTLY

COMPRESSIBLE CO-PROCESSED EXCIPIENT FOR

TABLET FORMULATIONS

SANJAYKUMAR S PATEL

74 24-Jul-20 Hall 01 182520820003 KHAN SALAUDDIN MD OSAMA MRW404P 20 252 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN, DEVELOPMENT AND OPTIMISATION OF

FEBUXOSTAT TRANSDERMAL PATCHDR MAULIK R MEHTA

75 24-Jul-20 Hall 01 182520820006 PATEL VIMALKUMAR BIPINBHAI MRW404P 20 252 MP Pharmaceutics

CO PROCESSED, DC,


AT

DEVELOPMENT OF NOVEL DIRECTLY COMPRESSIBLE

CO-PROCESSED ADJUVANT FOR CHEWABLE TABLETSANJAYKUMAR S PATEL

76 24-Jul-20 Hall 01 182600820005SHAIKH MOHAMMEDMUJAMMIL

JAKIRHUSENMRW404P 20 260 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND OPTIMIZATION OF MULTIPLE

UNIT PELLET SYSTEM (MUPS) OF MESALAMINE USING

EXTRUSION-SPHERONIZATION TECHNIQUE

DR. KUNAL N. PATEL

77 24-Jul-20 Hall 01 182860820003 GOSWAMI SIDDHARTH MRW404P 20 286 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT & EVALUATION OF

KOJIC ACID NANOFIBRE FOR TOPICAL DELIVERYDR. NISHITH PATEL

78 24-Jul-20 Hall 02 182070820004 NIHAL CHANDNIWALA MRW404P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF LULICONAZOLE

TOPICAL FILM-FORMING SPRAYDR. VISHNU M. PATEL

79 24-Jul-20 Hall 02 182070820005 RAJEBHAI FAYEJABANU SIRAJAHMED MRW404P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



MUCOADHESIVE BUCCAL FILMS OF ITRACONAZOLE

FOR ORAL CANDIDIASIS

DR. VISHNU M. PATEL

80 24-Jul-20 Hall 02 182470820004 Patel Rima Sureshbhai MRW404P 20 247 MP Pharmaceutics MISCELANEOUSFORMULATION AND CHARACTERIZATION OF

LIQUISOLID COMPACTS OF CILOSTAZOL.MR. VIJAY PATEL

81 24-Jul-20 Hall 02 182520820001 ACHARYA AMIRAS RAJNIKANT MRW404P 20 252 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN AND DEVELOPMENT OF APREMILAST

SUSTAINED RELEASE TABLETDR ALPESHBHAI D PATEL

82 24-Jul-20 Hall 02 182520820004 PATEL AFIKA JAKIRHUSEN MRW404P 20 252 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND CHARACTERIZATION OF

BLONANSERIN TABLET USING LIQUID SOLID

TECHNIQUE

DR MAULIK R MEHTA

of 27



Code

College_

Code

Branch_T




83 24-Jul-20 Hall 02 182600820002 GUPTA MONIKA ASHOKKUMAR MRW404P 20 260 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT AND CHARACTERIZATION OF SELF

EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF

UBIDECARENONE FOR ENHANCING SOLUBILITY AND

STABILITY

DR. KUNAL N. PATEL

84 24-Jul-20 Hall 02 182860820002 GAJJAR PINALBEN JITENDRABHAI MRW404P 20 286 MP PharmaceuticsNANO SUSPENSION/EMULSION,



PALIPERIDONE LOADED NANOSTRUCTURED LIPID

CARRIERS

MR.KRUNAL DETHOLIA

85 24-Jul-20 Hall 02 182860820004 KHATRI RITIKSHA SUNILKUMAR MRW404P 20 286 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FABRICATION AND OPTIMIZATION OF FEBUXOSTAT

LOADED NANOSTRUCTURED LIPID CARRIER BY 32

FULL FACTORIAL DESIGN

MR. UMANG VARIA

86 24-Jul-20 Hall 03 182250820001 KHARADI PIYUSHKUMAR JAYSINGBHAI MRW404P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



FILMS OF APIXABANDR.SHAILESH T.PRAJAPATI

87 24-Jul-20 Hall 03 182250820002 PATEL DHRUVIL SHAILESHKUMAR MRW404P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF DELAYED

RELEASE TABLETS OF IVABRADINE HYDROCHLORIDE

DR. SHAILESH T.

PRAJAPATI

88 24-Jul-20 Hall 03 182250820003 PATEL MAHESHWARI GHANSHYAMBHAI MRW404P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



FILMS OF CARVEDILOLDR. KEYUR S. PATEL

89 24-Jul-20 Hall 03 182600820004 PATEL PRUTHA KARTIK MRW404P 20 260 MP Pharmaceutics OTHER (KINDLY SPECIFY)PULSATILE DRUG

DELIVERY SYSTEM

DEVELOPMENT AND OPTIMIZATION OF PRESS-

COATED TABLETS OF ACEBROPHYLLINE FOR THE

TREATMENT OF NOCTURNAL BRONCHIAL ASTHMA

DR. KUNAL N. PATEL

90 24-Jul-20 Hall 03 182780820002 Purohit Kusum Shankarsinh MRW404P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION EVALUATION AND OPTIMIZATION OF

ORODISPERSIBLE FILMS OF NEBIVOLOL

HYDROCHLORIDE.

DR.VIKRAM PANDYA

91 24-Jul-20 Hall 03 182780820003 YADAV DIMPLE SHYAMKUMAR MRW404P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



TABLETS OF CINNARIZINE.MS.JIMMY M.LIMBACHIYA

92 24-Jul-20 Hall 03 182860820005 PATEL SHIVANI PRAKASHKUMAR MRW404P 20 286 MP Pharmaceutics OTHER (KINDLY SPECIFY) ANN

DEVELOPMENT OF ARTIFICAL NEURAL NETWORK FOR

SUSTAINED RELEASE MONOLITHIC TABLET USING

DISCRIMINATIVE DISSOLUTION TEST METHOD

MR.KRUNAL DETHOLIA

93 24-Jul-20 Hall 03 182860820006 PRAJAPATI MANISH PRABHUDAS MRW404P 20 286 MP Pharmaceutics MULTIPARTICULATE


POLYMERIC IDEBENONE SPHERICAL CRYSTALS BY

EMULSION SOLVENT DIFFUSION TECHNIQUE FOR

SOLUBILITY ENHANCEMENT

MR. UMANG VARIA

94 24-Jul-20 Hall 04 182070820003 NADIYA SAPANABEN RAJESHBHAI MRW404P 20 207 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

PREPARATION AND EVALUATION OF OPHTHALMIC IN-

SITU GEL OF ITRACONAZOLEDR ANAND K PATEL

95 24-Jul-20 Hall 04 182230828002 SHAH DHWANI MANISHKUMAR MRW404P 28 223 MPPharmaceutical

Technology

NANO SUSPENSION/EMULSION,



INHALABLE DRY POWDER CONTAINING ROFLUMILAST

PREPARED BY FREEZE DRYING METHOD

DR. ALIASGAR J

KUNDAWALA

96 24-Jul-20 Hall 04 182250820004 RAO AKSHAR NIKHILESHKUMAR MRW404P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FLOATING

TABLETS OF QUETIAPINE FUMARATEDR. KEYUR S. PATEL

97 24-Jul-20 Hall 04 182250820005 THAKOR NILESHKUMAR MANKAJI MRW404P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



TABLETS OF CLOMIPRAMINE HYDROCHLORIDEDR. ZIL PATEL

98 24-Jul-20 Hall 04 182470820002 PATEL DHAVAL ASHISHBHAI MRW404P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF FAST

DISSOLVING SUBLINGUAL FILM OF

CYANOCOBALAMIN.

MR. ANIL G. RAVAL

99 24-Jul-20 Hall 04 182470820003 PATEL PRACHI RAJENDRAKUMAR MRW404P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORALLY

DISINTEGRATING FILMS OF DEXTROMETHORPHAN

HYDROBROMIDE USING QUALITY BY DESIGN

APPROACH.

DR. DHARA PATEL

100 24-Jul-20 Hall 04 182520820005 PATEL MANESHKUMAR AMRUTLAL MRW404P 20 252 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DESIGN AND DEVELOPMENT OF ORODISPERSIBLE

FILM OF LAMOTRIGINE

DR MAULIKKUMAR J

PATEL

101 24-Jul-20 Hall 04 182780820001 PILLAI ARCHANA ANIL MRW404P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



DISSOLVING TABLETS OF FEBUXOSTAT.DR.KINJAL P. SOLANKI

of 27



Code

College_

Code

Branch_T




102 24-Jul-20 Hall 05 182240824001 HEENABEN MUKUNDBHAI PATEL MRW404P 24 224 MPPharmaceutical Quality


METHOD

DEVELOPMENT AND

VALIDATION BY

HPLC


DEVELOPMENT AND VALIDATION FOR ESTIMATION

OF REMOGLIFLOZIN ETABONATE IN TABLET DOSAGE

FORM

DR. HIRAL PANCHAL

103 24-Jul-20 Hall 05 182240824003 Nimavat Tanveeben Govindbhai MRW404P 24 224 MPPharmaceutical Quality


METHOD

DEVELOPMENT AND

VALIDATION BY

HPLC



OF ALPELISIB BY HPLC IN PHARMACEUTICAL DOSAGE

FORM

DR. HIRAL PANCHAL

104 24-Jul-20 Hall 05 182240824004 RAVAL JEET MANOJKUMAR MRW404P 24 224 MPPharmaceutical Quality


METHOD

DEVELOPMENT AND

VALIDATION BY

HPLC



OF ALPELISIB BY HPLC IN PHARMACEUTICAL DOSAGE

FOR STABILITY INDICATING HPLC METHOD


OF PEXIDARTINIB IN PHARMACEUTICAL DOSAGE

FORM

MRS. MITALI JASANI

105 24-Jul-20 Hall 05 182240824005 Shah Ami Kaushikbhai MRW404P 24 224 MPPharmaceutical Quality



INDICATING HPLC METHOD FOR ESTIMATION OF

RASAGILINE MESYLATE IN TABLET DOSAGE FORM

MRS. MITALI JASANI

106 24-Jul-20 Hall 05 182240824006 Sheetal Rajendrakumar Sheth MRW404P 24 224 MPPharmaceutical Quality


METHOD

DEVELOPMENT AND

VALIDATION BY

HPLC


VALIDATION FOR ESTIMATION OF FEDRATINIB IN

PHARMACEUTICAL DOSAGE FORM BY HPLC

MS. DIVYA THAKKAR

107 24-Jul-20 Hall 05 182240824007 Tiwari Annu Rajeshkumar MRW404P 24 224 MPPharmaceutical Quality




TEICOPLANIN AND ITS IMPURITIES IN


DR. HIRAL PANCHAL

108 24-Jul-20 Hall 05 182240824008 Tiwari Ashima Arunkumar MRW404P 24 224 MPPharmaceutical Quality




VILDAGLIPTIN AND ITS IMPURITIES IN


MS. DIVYA THAKKAR

109 24-Jul-20 Hall 05 182240824009 Upadhyay Kalpeshkumar Jagdishchandra MRW404P 24 224 MPPharmaceutical Quality


METHOD

DEVELOPMENT AND

VALIDATION BY

HPLC


VALIDATION FOR ESTIMATION OF TIOPRONIN IN

BULK AND PHARMACEUTICAL DOSAGE FORMS BY

HPLC

DR. HIRAL PANCHAL

110 24-Jul-20 Hall 06 182470824005 PANCHAL KRISHNA BHARATBHAI MRW404P 24 247 MPPharmaceutical Quality




ESTIMATION OF REMOGLIFILOZIN ETABONATE BY

HPLC IN BULK AND PHARMACEUTICAL DOSAGE

FORMS.

KAUSHIK PATEL

111 24-Jul-20 Hall 06 182600824003 PANCHAL HITAISHI JAGDISHKUMAR MRW404P 24 260 MPPharmaceutical Quality



INDICATING ASSAY METHOD FOR ESTIMATION OF

TOFACITINIB CITRATE IN ITS EXTENDED RELEASE

TABLETS

MRS. HETAL K. PATEL

112 24-Jul-20 Hall 06 182780824002 NINAMA NITAKUMARI BACHUBHAI MRW404P 24 278 MPPharmaceutical Quality


METHOD

DEVELOPMENT

RP-HPLC method devlopment and validation for the

estimation of fedratinib in pharmaceutical dosage

form

DR SANDIP DHOLAKIA

113 24-Jul-20 Hall 06 182860824002 CHANDEKAR YOJANA MADHUKAR MRW404P 24 286 MPPharmaceutical Quality



INDICATING RP-HPLC METHOD FOR ESTIMATION OF

FLUCLOXACILLIN SODIUM IN ITS TABLET DOSAGE

FORM.

MS. MINAKSHI M. DHORU

114 24-Jul-20 Hall 06 182860824003 KURMI AMBIKA JANARDAN MRW404P 24 286 MPPharmaceutical Quality



INDICATING HPTLC METHOD FOR ESTIMATION OF

MIRABEGRON FROM ITS PHARMACEUTICAL

FORMULATION.

MRS. BINNY D. MEHTA

of 27



Code

College_

Code

Branch_T




115 24-Jul-20 Hall 06 182860824004 KUSHAWAHA SUNITA KAMALDEVSINGH MRW404P 24 286 MPPharmaceutical Quality




RIVAROXABAN AND ASPIRIN FROM SYNTHETIC

MIXTURE.

DR. PINAK R. PATEL

116 24-Jul-20 Hall 06 182860824006 PANCHAL RIMABAHEN YOGESHBHAI MRW404P 24 286 MPPharmaceutical Quality

AssurancePROCESS VALIDATION

PROCESS VALIDATION OF OPTIMIZED FORMULATION

OF VILDAGLIPTIN TABLET DOSAGE FORMDR. MANDEV B. PATEL

117 24-Jul-20 Hall 06 182860824013 YADAV VARSHA RAMKUMAR MRW404P 24 286 MPPharmaceutical Quality




CELECOXIB AND AMLODIPINE FROM SYTHETIC

MIXTURE.

MRS. BINNY D. MEHTA

118 24-Jul-20 Hall 07 182470824002 GOHEL VRUSHIKA RANJITSINH MRW404P 24 247 MPPharmaceutical Quality



VALIDATION OF STABILITY INDICATING HPLC METHOD

FOR SIMULTANEOUS ESTIMATION OF HALOBETASOL

PROPIONATE AND TAZAROTENE IN SYNTHETIC

MIXTURE.

MS.KUNJAL VEGAD

119 24-Jul-20 Hall 07 182470824003 JAGIRDAR DAYAWATI ANANTKUMAR MRW404P 24 247 MPPharmaceutical Quality




FOR ESTIMATION OF PEXIDARTINIB IN BULK AND


MS.DHWANI SHAH

120 24-Jul-20 Hall 07 182470824004 PAEL RAJARSHREE KETANBHAI MRW404P 24 247 MPPharmaceutical Quality




FOR SIMULTANEOUS ESTIMATION OF KETOROLAC

TROMETHAMINE AND ALCAFTADINE IN OPTHALMIC

SYNTHETIC MIXTURE.

MR.KAUSHIK PATEL

121 24-Jul-20 Hall 07 182470824011 PATEL MANALIBEN SUNILBHAI MRW404P 24 247 MPPharmaceutical Quality

AssuranceBIOANALYTICAL

BIOANALYTICAL METHOD DEVELOPMENT, METHOD

VALIDATION AND STABILITY FOR ESTIMATION OF

CHLORTHALIDONE IN HUMAN PLASMA BY USING LC-

ESI-MS/MS

MR. JAYMIN G PATEL

122 24-Jul-20 Hall 07 182600824005 SHAH BIJAL JITENDRAKUMAR MRW404P 24 260 MPPharmaceutical Quality



VALIDATION OF ELEMENTAL IMPURITIES OF

AMINOCAPROIC ACID TABLETS AND POTASSIUM

CHLORIDE EXTENDED RELEASE TABLETS BY

INDUCTIVELY COUPLED PLASMA MASS

SPECTROMETRY (ICP-MS)

MRS. VANITA MARVANIYA

123 24-Jul-20 Hall 07 182860824001 BHATT JIGNA HEMANTKUMAR MRW404P 24 286 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF

CHROMATOGRAPHIC ANALYTICAL METHODS FOR

DETERMINATION OF AMLODIPINE BESYLATE,

ROSUVASTATIN CALICIUM AND TELMISARTAN FROM

SYNTHETIC MIXTURE

DR. PINAK R. PATEL

124 24-Jul-20 Hall 07 182860824007 PANJABI RESHMA MURLIDHAR MRW404P 24 286 MPPharmaceutical Quality




SAXAGLIPTIN, DAPAGLIFLOZIN AND METFORMIN

HYDROCHLORIDE BY HPLC IN TABLET DOSAGE FORM


125 24-Jul-20 Hall 07 182860824008 PATEL HETALBEN MULJIBHAI MRW404P 24 286 MPPharmaceutical Quality




OF KETOROLAC TROMETHAMINE AND ALCAFTADINE

BY RP-HPLC IN BULK AND PHARMACEUTICAL DOSAGE

FORM

MRS. BINNY D. MEHTA

126 24-Jul-20 Hall 08 182240824002 Modi Palak Ghanshyambhai MRW404P 24 224 MPPharmaceutical Quality


STABILITY INDICATING HPLC METHOD DEVELOPMENT

AND VALIDATION FOR SIMULTANEOUS ESTIMATION

OF AMLODIPINE AND CELECOXIB IN

PHARMACEUTICAL DOSAFE FORMS

DR. HIRAL PANCHAL

of 27



Code

College_

Code

Branch_T




127 24-Jul-20 Hall 08 182250824001 ASODIYA AXEN KIRIT MRW404P 24 225 MPPharmaceutical Quality


STABILITY INDICATING RP HPLC METHOD

DEVELOPMENT AND VALIDATION OF SELINEXOR IN

TABLET

DR. SAMIR C. PATEL

128 24-Jul-20 Hall 08 182250824002 CHAUHAN BHAVESHKUMAR KHANABHAI MRW404P 24 225 MPPharmaceutical Quality



AND VALIDATION OF BREMELANOTIDE IN INJECTIONDR. SAMIR C. PATEL

129 24-Jul-20 Hall 08 182470824013 SONI POOJA HARESHKUMAR MRW404P 24 247 MPPharmaceutical Quality


STABILITY INDICATING METHOD DEVELOPMENT AND


OF ROSUVASTATIN CALCIUM AND VITAMIN D3 BY

HPLC IN BULK AND PHARMACEUTICAL DOSAGE FORM

DR.VINAY DARJI

130 24-Jul-20 Hall 08 182600824004 PATEL SHRADDHABEN JAYESHKUMAR MRW404P 24 260 MPPharmaceutical Quality



INDICATING ASSAY RP-HPLC METHOD FOR

OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION

MRS. HETAL K. PATEL

131 24-Jul-20 Hall 08 182600824006 YADAV MEENAKSHI MAHESHKUMAR MRW404P 24 260 MPPharmaceutical Quality



INDICATING RP-HPLC METHOD FOR TICLOPIDINE

HYDROCHLORIDE AND ITS IMPURITIES IN


MS. VANITA H.

MARVANIYA

132 24-Jul-20 Hall 08 182860824009 PATEL JAY RAJESHBHAI MRW404P 24 286 MPPharmaceutical Quality



METHODS FOR SIMULTANEOUS DETERMINATION OF

PREDNISOLONE AND ASPIRIN IN SYNTHETIC MIXTURE

DR. PINAK R. PATEL

133 24-Jul-20 Hall 08 182860824012 PATEL PRIYANSHI MEHULBHAI MRW404P 24 286 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF RP-HPLC

METHOD FOR QUANTIFICATION OF FENTICONAZOLE

NITRATE AND ITS RELATED SUBSTANCE IN SOFT

GELATIN CAPSULE DOSAGE FORM.


134 24-Jul-20 Hall 09 182250824003 PATEL JANKHANABEN DINESHBHAI MRW404P 24 225 MPPharmaceutical Quality


STABILITY INDICATING CHROMATOGRAPHIC METHOD

DEVELOPMENT AND VALIDATION OF DOLUTEGRAVIR

AND LAMIVUDINE IN TABLET DOSAGE FORM

DR. DEEPA R. PATEL

135 24-Jul-20 Hall 09 182250824005 PATEL USHMABEN BABUBHAI MRW404P 24 225 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF REMOGLIFLOZIN

IN TABLET DOSAGE FORM

DR. DEEPA R. PATEL

136 24-Jul-20 Hall 09 182250824007 PRAJAPATI UTTAM MAGANLAL MRW404P 24 225 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF ALPELISIB IN

TABLET DOSAGE FORM

DR. DEEPA R. PATEL

137 24-Jul-20 Hall 09 182470824007 PATEL BHOOMI VIJAYBHAI MRW404P 24 247 MPPharmaceutical Quality




OF LESINURAD AND ALLOPURINOL BY HPLC IN BULK

AND PHARMACEUTICAL DOSAGE FORMS.

JAYMIN.G.PATEL

138 24-Jul-20 Hall 09 182470824009 PATEL DHRUVINABEN MANOJKUMAR MRW404P 24 247 MPPharmaceutical Quality



VALIDATION OF STABILITY INDICATING RP-HPLC

METHOD FOR SIMULTANEOUS ESTIMATION OF

ACLIDINIUM BROMIDE AND FORMOTEROL

FUMARATE IN SYNTHETIC MIXTURE.

MR. JAYMIN G PATEL

139 24-Jul-20 Hall 09 182470824010 PATEL MAITRIBAHEN JAYANTIBHAI MRW404P 24 247 MPPharmaceutical Quality




OF DOLUTEGRAVIR,EMTRICITABINE AND TENOFOVIR

ALAFENAMIDE BY HPLC IN BULK AND

PHARMACEUTICAL DOSAGE FORM.

MS.ANKITA PATEL

of 27



Code

College_

Code

Branch_T




140 24-Jul-20 Hall 09 182780824001 HINGU JAGRUTI CHHAGANLAL MRW404P 24 278 MPPharmaceutical Quality



INDICATING RP-HPLC METHOD FOR THE ESTIMATION

OF ENTRECTINIB IN PHARMACEUTICAL DOSAGE

FORM.

DR RAJESH PATEL

141 24-Jul-20 Hall 09 182780824003 PATEL MANSI MUKESHKUMAR MRW404P 24 278 MPPharmaceutical Quality




OF REMOGLIFLOZIN ETABONATE IN ITS TABLET

DOSAGE FORM

DR RAJESH PATEL

142 27-Jul-20 Hall 01 182050820011 VAHORA MOHAMMAD TALHA MUSTUFA MRW404P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


SYSTEMIC DEVELOPMENT OF TOPICAL VALSARTAN

WOUND CARE FORMULATIONDR. VAISHALI T. THAKKAR

143 27-Jul-20 Hall 01 182130820004 KAKASANIA JEEL PINAKINBHAI MRW404P 20 213 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


TOPICAL FOAM FORMULATION OF FLUCONAZOLE

FOR SKIN FUNGAL INFECTIONDR.PRACHI PANDEY

144 27-Jul-20 Hall 01 182130828004 PANDYA BHAVIN DIVYESHKUMAR MRW404P 28 213 MPPharmaceutical

Technology

IR, ODT, DT, SUBLINGUAL, FAST


SOLID DISPERSION ADSORBATE: AN EFFECTIVE

METHOD TO ENHANCE DISSOLUTION AND FLOW

PROPERTIES OF CLOZAPINE

DR ASHOK MAHAJAN

145 27-Jul-20 Hall 01 182350820001 JADHAV DIVYA HEMANTBHAI MRW404P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN DEVELOPMENT AND OPTIMIZATION OF

MUCOADHESIVE IN-SITU NASAL GEL CONTAINING

XYLOMETAZOLINE HYDROCHLORIDE

DR HITESH JAIN

146 27-Jul-20 Hall 01 182350820002 SHARMA KUSUM NARESH MRW404P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION, DEVELOPMENT AND OPTIMIZATION

OF PAROXETINE HYDROCHLORIDE LOADED

TRANSDERMAL PATCH

DR ASIT R SAHU

147 27-Jul-20 Hall 01 182350820004 SHUKLA RUCHI RAJDHAR MRW404P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN DEVELOPMENT AND OPTIMIZATION OF

TOPICAL BIGEL CONTAINING MOMETASONE FUROATEDR HITESH JAIN

148 27-Jul-20 Hall 01 182350820005 SRIVASTAVA ANKITA ASHOK MRW404P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF FUSIDIC ACID

EMULGELDR. SHARAV DESAI

149 27-Jul-20 Hall 01 182450820001 ARYA UDAYKUMAR KISHANLAL MRW404P 20 245 MP Pharmaceutics OTHER (KINDLY SPECIFY) MATRIX TABLETSFORMULATION AND EVALUATION OF MATRIX

TABLETS OF QUETIAPINE FUMARATEDR. P. H. PRAJAPATI

150 27-Jul-20 Hall 02 182020820001 PATEL KRUPALI SHAILESHKUMAR MRW404P 20 202 MP Pharmaceutics OTHER (KINDLY SPECIFY)

NANOPARTICLES

LOADED BUCCAL

FILMS

DESIGN AND EVALUATION OF ORAL FILM

CONTAINING NIMODIPINE NANOPARTICLESDR. SAIKAT PANDE

151 27-Jul-20 Hall 02 182020820002 SHALINI DWIVEDI MRW404P 20 202 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT AND EVALUATION OF OLMESARTAN

MEDOXOMIL LOADED SNEDDSDR. AJAY B. SOLANKI

152 27-Jul-20 Hall 02 182050820006 Pankaj Kumar MRW404P 20 205 MP Pharmaceutics

CO PROCESSED, DC,


AT

MICROWAVE ASSISTED SOLID DISPERSION

TECHNIQUE: QUICK AND EFFICIENT METHOD TO

ENHANCE DISSOLUTION OF CILOSTAZOL

DR.CHETNA D. MODI

153 27-Jul-20 Hall 02 182050820010RAULJI JAYVANTIKAKUNVERBA

DHARMPALSINHMRW404P 20 205 MP Pharmaceutics

CO PROCESSED, DC,


AT

STUDIES IN THE DEVELOPMENT OF SOLID ORAL

DOSAGE FORM USING INTRAGRANULAR AND

EXTRAGRANULAR SILICON DIOXIDE AS A

COMPRESSION AID ALONG WITH BINDERS

DR. MUKESH C. GOHEL

154 27-Jul-20 Hall 02 182130828003 MODI JANVIBEN KETANBHAI MRW404P 28 213 MPPharmaceutical

Technology

DELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF INTRANASAL

SPRAY OF PRAMIPEXOLE DIHYDROCHLORIDEDR. MEENAKSHI PATEL

155 27-Jul-20 Hall 02 182350820003 SHETH MAITRY SANKETKUMAR MRW404P 20 235 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


SUSTAINED RELEASE FLOATING MICROBALLOONS

CONTAINING ALLOPURINOL

DR HITESH JAIN

156 27-Jul-20 Hall 02 182350820007 Trivedi Monika Vijaybhai MRW404P 20 235 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION, DEVELOPMENT AND EVALUATION OF

IMMEDIATE RELEASE FIXED DOSE COMBINATION OF

ANTI-HYPERTENSIVE DRUG

DR ASIT R SAHU

157 27-Jul-20 Hall 02 182350820008 VEEDHI RAJENDRAKUMAR RATHAWA MRW404P 20 235 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF IN-SITU

OPHTHALMIC GEL CONTAINING ECONAZOLE NITRATEDR SHARAV DESAI

of 27



Code

College_

Code

Branch_T




158 27-Jul-20 Hall 03 182050820003 Dalwadi Saloniben Bharatbhai MRW404P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


HYBRID LIQUISOLID TECHNIQUE: A NOVEL APPROACH

TO ENHANCE IN VITRO PERFORMANCE OF AN

ANTIDIABETIC DRUG

DR. VAISHALI T. THAKKAR

159 27-Jul-20 Hall 03 182050820005 PANCHAL SUMATI ANAMISHARAN MRW404P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


COMPARATIVE EVALUATION OF TWO

CONTEMPORARY METHODS FOR ENHANCING IN-

VITRO DISSOLUTION OF TELMISARTAN EMPLOYING

THE CURRENT REGULATORY REQUIREMENTS


160 27-Jul-20 Hall 03 182050820009 PATHAN LUKMANKHAN SHERKHAN MRW404P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


ENHANCEMENT OF SOLUBILITY BY USING DIFFERENT

TECHNIQUES AND DEVELOPMENT OF NOVEL

BOSENTAN FORMULATION

DR.CHETNA D. MODI

161 27-Jul-20 Hall 03 182130820009 Shah Shrusti Sandip MRW404P 20 213 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION DEVELOPMENT AND OPTIMIZATION

OF SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM

OF FUROSEMIDE

DR. NAAZNEEN SURTI

162 27-Jul-20 Hall 03 182130828006 RAIYANI DHARABEN BALUBHAI MRW404P 28 213 MPPharmaceutical

Technology

DELAYED/EXTENDED RELEASE,

FLOATING, INSITU

OCULAR NANOSYSTEM FOR PROLONGED DELIVERY OF

FLURBIPROFEN AND GATIFLOXACINDR. NAAZNEEN SURTI

163 27-Jul-20 Hall 03 182440820001 Gandhi Rukma Shishirkumar MRW404P 20 244 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



DISSOLVING ORAL FILM OF ANTIPSHYCHOTIC AGENT

PALIPERIDONE.

M. RAHIL BHURA

164 27-Jul-20 Hall 03 182440820002 Jayswal Durgeshkumar Dipakkumar MRW404P 20 244 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



TABLET OF BUSPIRONE HYDROCHLORIDEM. RAHIL BHURA

165 27-Jul-20 Hall 03 182440820003 Solanki Nikulkumar Raghabhai MRW404P 20 244 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



DISSOLVING FILM OF IVABRADINE HCLMEHUL VYAS

166 27-Jul-20 Hall 04 182050820002 CHAUDHARI RUSHIKESH MRW404P 20 205 MP Pharmaceutics MULTIPARTICULATEDESIGN AND DEVELOPMENT OF CLOZAPINE

MINITABLET USING QUALITY BY DESIGN APPROACHMR. HARDIK B. RANA

167 27-Jul-20 Hall 04 182050820004 Limarkar Nirmalaben Manubhai MRW404P 20 205 MP Pharmaceutics MULTIPARTICULATE


CEFIXIME GRANULES BY EMPLOYING SYSTEMATIC

FORMULATION APPROACH FOR PEDIATRIC

APPLICATION

DR. MUKESH C. GOHEL

168 27-Jul-20 Hall 04 182050820007 PATEL DRASHTI SUBHASHCHANDRA MRW404P 20 205 MP PharmaceuticsNANO SUSPENSION/EMULSION,


SUPERSTAURATED DRUG DELIVERY SYSTEM: AN

APPROACH TO ENHANCE IN-VITRO DISSOLUTION OF

ATOVAQUONE

DR. MUKESH C. GOHEL

169 27-Jul-20 Hall 04 182130820001 CHAVDA DOLLY TRIKAMLAL MRW404P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

PREPARATION AND CHARACTERIZATION OF VAGINAL

DOSAGE FORM OF NEVIRAPINEDR. NAAZNEEN SURTI

170 27-Jul-20 Hall 04 182130820003 KADAM RUCHITA PANDURANG MRW404P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DISSOLUTION ENHANCEMENT & COLON TARGETED

DELIVERY OF RIFAXIMIN IN THE MANAGEMENT OF

INFLAMMATORY BOWEL DISEASE

DR. MANISHA LALAN

171 27-Jul-20 Hall 04 182130820005 MEHTA KHYATI HITESHKUMAR MRW404P 20 213 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


LIQUISOLID TECHNIQUE FOR DISSOLUTION

ENHANCEMENT OF TYROSINE KINASE INHIBITORDR ASHOK MAHAJAN

172 27-Jul-20 Hall 04 182130828002 Menon Maanika Kashyap MRW404P 28 213 MPPharmaceutical

TechnologyMISCELANEOUS

MANAGEMENT OF OVERACTIVE BLADDER IN WOMEN

: INTRAVAGINAL RING CONTAINING DARIFENACINDR. MANISHA LALAN

173 27-Jul-20 Hall 04 182350820006 SURVE ROOSHALI SANJAY MRW404P 20 235 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF MICROSPONGE

BASED COLON SPECIFIC TABLET OF MEBENDAZOLEDR SHARAV DESAI

174 27-Jul-20 Hall 05 182050820001 BHAVSAR NIRVISHA VIPULCHANDRA MRW404P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY)VAGINAL DRUG

DELIVERY SYSTEM

DEVELOPMENT OF NEWER VAGINAL FORMULATION

OF HYDROXYPROGESTERONE CAPROATE FOR THE

REGULATED MARKET


175 27-Jul-20 Hall 05 182050820008 PATEL GRISHMA NILESHKUMAR MRW404P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY) PASTILLATIONDEVELOPMENT AND EVALUATION OF PASTILLES

CONTAINING PIPERINE AND ROSUVASTATINMR. HARDIK B. RANA

of 27



Code

College_

Code

Branch_T




176 27-Jul-20 Hall 05 182130820002 JYOTI JHA MRW404P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)NASAL DRUG

DELIVERY SYSTEM

FORMULATION AND EVALUATION OF MUPIROCIN

AND BECLOMETHASONE INSITU GELLING BIO-

ADHESIVE NASAL FORMULATION FOR MRSA INDUCED

RHINOSINUSITIS

DR.PRIYAL R PATEL

177 27-Jul-20 Hall 05 182130820006 PATEL JYOTIBEN SANJAYBHAI MRW404P 20 213 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND EVALUATION OF SUBLINGUAL

SPRAY OF DOMPERIDONEDR VANDANA PATEL

178 27-Jul-20 Hall 05 182130820007 RAHANGDALE MRUNAL GANESH MRW404P 20 213 MP PharmaceuticsVESICULAR DRUG DELIVERY

SYSTEM

TRANSETHOSOMAL TOPICAL GEL OF APREMILAST FOR

TREATMENT OF PSORIASISDR.PRACHI PANDEY

179 27-Jul-20 Hall 05 182130820008 RAMAIYA ZEEL MAHESH MRW404P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF GASTRO

RETENTIVE MULTIPARTICULATE SYSTEM OF

LAMOTRIGINE

DR. MEENAKSHI PATEL

180 27-Jul-20 Hall 05 182130828005 PATEL DIVYA CHANDRAKANTBHAI MRW404P 28 213 MPPharmaceutical

TechnologyMISCELANEOUS

FORMULATION AND EVALUATION OF NEPAFENAC

MICROEMULSION BASED IN-SITU GEL FOR OCULAR

PAIN MANAGEMENT

DR.PRIYAL PATEL

181 27-Jul-20 Hall 05 182350820009 VRUNDABEN PATEL MRW404P 20 235 MP Pharmaceutics MULTIPARTICULATE

FORMULATION, DEVELOPMENT AND OPTIMIZATION

OF EXTENDED RELEASE PELLETS CONTAINING ANTI-

EPILEPTIC DRUG

DR ASIT R SAHU

182 27-Jul-20 Hall 06 182020824001 VASANI MEGHA VIRENDRAKUMAR MRW404P 24 202 MPPharmaceutical Quality


ANALYTICAL

METHOD

DEVELOPMENT


INDICATING HPTLC METHOD FOR LORCASERIN

HYDROCHLORIDE HEMIHYDRATE IN BULK AND

TABLET DOSAGE FORM

DR.RAJENDRAKUMAR.S.M

EHTA

183 27-Jul-20 Hall 06 182020824002 PATEL CHANDNI SAMIRBHAI MRW404P 24 202 MPPharmaceutical Quality


ANALYTICAL

METHOD

DEVELOPMENT



DAPAGLIFLOZIN PROPANEDIOL AND SAXAGLIPTIN

HYDROCHLORIDE DIHYDRATE IN BULK AND

SYNTHETIC MIXTURE

DR.(MRS)

ANANDKUMARI.D.CAPTAI

N

184 27-Jul-20 Hall 06 182050824003 Padavi Sawankumar Rameshbhai MRW404P 24 205 MPPharmaceutical Quality


STABILITY INDICATING HIGH PERFORMANCE THIN

LAYER CHROMATOGRAPHIC METHOD FOR

SIMULTANEOUS ESTIMATION OF FLUTICASONE

PROPIONATE AND MUPIROCIN IN COMBINED

DOSAGE FORM

MR. HITESH G. RAVAL

185 27-Jul-20 Hall 06 182050824006 RATHVA PARULBEN JETHABHAI MRW404P 24 205 MPPharmaceutical Quality


STABILITY INDICATING HIGH PERFORMANCE THIN

LAYER CHROMATOGRAPHIC METHOD FOR

ESTIMATION OF FINGOLIMOD HYDROCHLORIDE IN

PHARMACEUTICAL DOSAGE FORM AND ITS

DEGRADATION KINETIC STUDY

DR. KALPANA G PATEL

186 27-Jul-20 Hall 06 182150824001 DIXIT ANMOL RAJENDRAPRASAD MRW404P 24 215 MPPharmaceutical Quality



METHODS FOR SIMULTANEOUS ESTIMATION OF

FLUCONAZOLE AND ZINC PYRITHIONE IN LOTION

DR. GHANSHYAM

SHANGHANI

187 27-Jul-20 Hall 06 182230823004 PATEL KIRTAN PINAKIN MRW404P 23 223 MP Pharmaceutical Analysis SIMULTENEOUS ESTIMATION


METHODS FOR THE SIMULTANEOUS

QUANTIFICATION OF PERINDOPRIL ERBUMINE,

INDAPAMIDE AND AMLODIPINE BESILATE IN BULK

AND PHARMACEUTICAL DOSAGE FORM

DR. USMANGANI K.

CHHALOTIYA

188 27-Jul-20 Hall 06 182350824001 ADESHRA SHREYA DINESHBHAI MRW404P 24 235 MPPharmaceutical Quality




EFONIDIPINE HYDROCHLORIDE ETHANOLATE AND

TELMISARTAN IN THEIR SYNTHETIC MIXTURE

MS. GRISHMA PATEL

189 27-Jul-20 Hall 06 182350824002 Bandwala faiz shabbirHusain MRW404P 24 235 MPPharmaceutical Quality




TERBINAFINE HYDROCHLORIDE AND FLUTICASONE

PROPIONATE IN THEIR COMBINED DOSAGE FORM

MS. GRISHMA PATEL

of 27



Code

College_

Code

Branch_T




190 27-Jul-20 Hall 06 182350824003 CHUDASAMA VIRANGI HITESHBHAI MRW404P 24 235 MPPharmaceutical Quality




MUPIROCIN AND METHYLPREDNISOLONE IN THEIR

COMBINED DOSAGE FORM

MR. TEJAS PATEL

191 27-Jul-20 Hall 07 182050824005 PATEL TRUPAL KUMARI RAJESHBHAI MRW404P 24 205 MPPharmaceutical Quality


FORMULATION

DEVELOPMENT AND

METHOD

DEVELOPMENT

QBD ASSISTED FORMULATION DEVELOPMENT AND

ANALYTICAL METHOD DEVELOPMENT FOR

SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN AND

DEXAMETHASONE IN NOVEL OPHTHALMIC

FORMULATION

DR. PURVI A SHAH

192 27-Jul-20 Hall 07 182130824001 GONDALIA ISHITA ISHWARDAS MRW404P 24 213 MPPharmaceutical Quality



CHROMATOGRAPHIC METHODS FOR ESTIMATION OF

REMOGLIFLOZIN ETABONATE IN TABLET DOSAGE

FORM

DR. DIMAL A. SHAH

193 27-Jul-20 Hall 07 182130824004 TEWARI AYUSHI RAHUL MRW404P 24 213 MPPharmaceutical Quality



METHOD FOR THE STUDY OF VARDENAFIL

HYDROCHLORIDE TRIHYDRATE

DR. FALGUN A. MEHTA

194 27-Jul-20 Hall 07 182150824002 NISAD SAPNAKUMARI RAMRATAN MRW404P 24 215 MPPharmaceutical Quality


SIMULTANEOUS DEVELOPMENT AND VALIDATION OF

HPTLC METHOD FOR DETERMINATION OF

ZONISAMIDE AND CILOSTAZOL IN SYNTHETIC

MIXTURE.

DR. ZARNA DEDANIA

195 27-Jul-20 Hall 07 182230823001 DEVANSH KANSARA MRW404P 23 223 MP Pharmaceutical Analysis SIMULTENEOUS ESTIMATION


CHROMATOGRAPHIC METHODS FOR SIMULTANEOUS

ESTIMATION OF FIMASARTAN POTASSIUM,

ROSUVASTATIN CALCIUM AND AMLODIPINE

BESYLATE IN SYNTHETIC MIXTURE

DR. USMANGANI K.

CHHALOTIYA

196 27-Jul-20 Hall 07 182350824011 SHAH KESHA KIRANKUMAR MRW404P 24 235 MPPharmaceutical Quality


PROCESS VALIDATION OF METRONIDAZOLE FILM

COATED TABLETDR. PRASANNA PRADHAN

197 27-Jul-20 Hall 07 182450824001 Akhani Vaibhavi Nitinkumar MRW404P 24 245 MPPharmaceutical Quality


METHOD

DEVELOPMENT


VALIDATION FOR ESTIMATION OF PRUCALOPRIDE

SUCCINATE IN PHARMACEUTICAL DOSAGE FORM

DR. LAXMAN M

PRAJAPATI

198 27-Jul-20 Hall 07 182450824003 PATEL KRUPABEN NARESHKUMAR MRW404P 24 245 MPPharmaceutical Quality


QUANTITATIVE

METHOD

DEVELOPMENT

QUANTITATIVE ANALYTICAL METHOD DEVELOPMENT

AND VALIDATION FOR TERIFLUNOMIDE IN


DR. LAXMAN M

PRAJAPATI

199 27-Jul-20 Hall 07 182450824004 SANYAL ASTHA PRAVINBHAI MRW404P 24 245 MPPharmaceutical Quality

AssuranceOTHER (KINDLY SPECIFY) QBD APPROACH


VALIDATION FOR SAROGLITAZAR MAGNESIUM IN

PHARMACEUTICAL DOSAGE FORM BY QBD

APPROACH

DR. CHHAGANBHAI N

PATEL

200 27-Jul-20 Hall 08 182050824001 CHAVDA NIRALI JAGDIPBHAI MRW404P 24 205 MPPharmaceutical Quality


SPECTROPHOTOMETRIC AND HIGH PERFORMANCE

THIN LAYER CHROMATOGRAPHIC METHOD FOR

SIMULTANEOUS DETERMINATION OF MOMETASONE

FUROATE AND MUPIROCIN IN COMBINED DOSAGE

FORM

MR. HITESH G. RAVAL

201 27-Jul-20 Hall 08 182050824002 MANIAR YASH PRADEEPBHAI MRW404P 24 205 MPPharmaceutical Quality


FORMULATION DEVELOPMENT AND SIMULTANEOUS

ESTIMATION OF FLUTICASONE PROPIONATE AND

OLOPATADINE HYDROCHLORIDE IN NEWLY

OPTIMIZED NASAL FORMULATION BY QBD APPROACH

DR. KALPANA G PATEL

202 27-Jul-20 Hall 08 182050824007 Rathwa Nikitaben Vijaykumar MRW404P 24 205 MPPharmaceutical Quality




DOXOFYLLINE AND MONTELUKAST SODIUM IN


DR. PURVI A SHAH

of 27



Code

College_

Code

Branch_T




203 27-Jul-20 Hall 08 182130824003 MATUNGI BHUPENDRABHAI PATEL MRW404P 24 213 MPPharmaceutical Quality

AssuranceOTHER (KINDLY SPECIFY) HYDROTROPY

CONCEPT OF HYDROTROPY IN DEVELOPMENT AND

VALIDATION OF RP-HPLC METHOD FOR

DETERMINATION OF GATIFLOXACIN IN BULK AND EYE

DROPS

DR. VANDANA B. PATEL

204 27-Jul-20 Hall 08 182150824003 THAKKAR HIREN GHANSHYAMBHAI MRW404P 24 215 MPPharmaceutical Quality


STABILITY INDICATING HPTLC METHOD

DEVELOPMENT AND VALIDATION OF CLOMIPRAMINE

HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE

FORM

DR. ZARNA DEDANIA

205 27-Jul-20 Hall 08 182230823003 PATEL JAYKUMAR KAUSHIKBHAI MRW404P 23 223 MP Pharmaceutical Analysis SIMULTENEOUS ESTIMATION


METHODS FOR THE SIMULTANEOUS ESTIMATION OF

MINOXIDIL AND FINASTERIDE IN BULK AND

MARKETED FORMULATION

MRS. JINAL TANDEL

206 27-Jul-20 Hall 08 182350824004 daraji hitanshi pareshkumar MRW404P 24 235 MPPharmaceutical Quality




EFONIDIPINE HYDROCHLORIDE ETHANOLATE AND

METOPROLOL SUCCINATE IN THEIR SYNTHETIC

MIXTURE

DR. PRASANNA PRADHAN

207 27-Jul-20 Hall 08 182350824005 KANSOTIA RUCHI MANGILAL MRW404P 24 235 MPPharmaceutical Quality




LULICONAZOLE AND TERBINAFINE HYDROCHLORIDE


DR. DHARA PATEL

208 27-Jul-20 Hall 08 182350824006 PARMAR RIPPLE NARENDRABHAI MRW404P 24 235 MPPharmaceutical Quality




ACECLOFENAC, TOLPERISONE AND PARACETAMOL IN

TABLET FORMULATION

DR. PRASANNA KUMAR

PRADHAN

209 27-Jul-20 Hall 09 182150824004 THUTAN SHWETABEN KAVDUBHAI MRW404P 24 215 MPPharmaceutical Quality



AND VALIDATION FOR ITRACONAZOLE AND

TERBINAFINE HYDROCHLORIDE IN COMBINED


DR. ZARNA DEDANIA

210 27-Jul-20 Hall 09 182230823002 PATEL ISHITA MANISHBHAI MRW404P 23 223 MP Pharmaceutical Analysis SIMULTENEOUS ESTIMATION



EMPAGLIFLOZIN, LINAGLIPTIN AND METFORMIN HCL

IN BULK AND IN ITS SYNTHETIC MIXTURE

MRS HARSHA D JANI

211 27-Jul-20 Hall 09 182350824007 PATEL HIRALBEN KAUSHIKBHAI MRW404P 24 235 MPPharmaceutical Quality




ALCAFTADINE AND KETOROLAC TROMETHAMINE IN

SYNTHETIC MIXTURE.

DR. DHARA PATEL

212 27-Jul-20 Hall 09 182350824008 Patel Kajalben Jayeshkumar MRW404P 24 235 MPPharmaceutical Quality




AZELNIDIPINE AND TELMISARTAN IN THEIR

SYNTHETIC MIXTURE

DR. PRASANNA KUMAR

PRADHAN

213 27-Jul-20 Hall 09 182350824009 Patel khyati jayendrabhai MRW404P 24 235 MPPharmaceutical Quality



CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS

ESTIMATION OF ATORVASTATIN CALCIUM AND

VITAMIN D3 (CHOLECALCIFEROL) IN THEIR COMBINED

DOSAGE FORM

DR. DHANANJAY

MESHRAM

214 27-Jul-20 Hall 09 182350824010 Radharapu Satchitkrishna Chandrashekhar MRW404P 24 235 MPPharmaceutical Quality




PAROXETINE HCL AND ETIZOLAM IN


DR. DHARA PATEL

of 27



Code

College_

Code

Branch_T




215 27-Jul-20 Hall 09 182450824002 PATEL ARATIBEN MANUBHAI MRW404P 24 245 MPPharmaceutical Quality




OF BILASTINE IN PHARMACEUTICAL DOSAGE FORM

DR. CHHAGANBHAI N

PATEL

216 27-Jul-20 Hall 09 182450824005 Shah Hemant Yogeshbhai MRW404P 24 245 MPPharmaceutical Quality




OF ZONISAMIDE IN PHARMACEUTICAL DOSAGE FORM

MR. PRUTHVIRAJ K

CHAUDHARY

217 28-Jul-20 Hall 01 182390820009 PATEL HEMAXIBEN HITENDRA MRW404P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DEVELOPMENT, EVALUATION AND OPTIMIZATION OF

DACARBAZINE LOADED LIPID NANOPARTICLE BASED

TOPICAL GEL

DR. KOMAL PARMAR

218 28-Jul-20 Hall 01 182510820001 PATHAN SURAIYA ASHRAFKHAN MRW404P 20 251 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF MEDICATED

NAIL LACQUER OF SERTACONAZOLE NITRATEDR. TUSHAR A. GOHIL

219 28-Jul-20 Hall 01 182510820002 SARVAIYA DIPASVIBEN DALPATBHAI MRW404P 20 251 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COLON

TARGETED MINI TABLETS OF ORNIDAZOLEDR. TUSHAR A. GOHIL

220 28-Jul-20 Hall 01 182540820001 BHARODIYA KISHAN VITTHALBHAI MRW404P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



SERTACONAZOLE NITRATE TOPICAL DOSAGE FORM

FOR THE TREATMENT OF FUNGAL DISEASE

DR. MANISH GOYANI

221 28-Jul-20 Hall 01 182540820003 KOLYA MEHRUNNISHA MAHAMAD MRW404P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



SERTACONAZOLE NITRATE TOPICAL SPRAY FOR THE

TREATMENT OF FUNGAL INFECTION

DR. MANISH GOYANI

222 28-Jul-20 Hall 01 182540820006 PATEL PINKISABEN SUBHASHBHAI MRW404P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BIFONAZOLE

ETHOSOMAL GEL FOR TOPICAL DRUG DELIVERYDR. MANISH GOYANI

223 28-Jul-20 Hall 01 182610820001 DAXINI KAPILKUMAR VINODBHAI MRW404P 20 261 MP Pharmaceutics OTHER (KINDLY SPECIFY)BIOAVAILABILITY

ENHANCEMENT

DEVELOPMENT OF ORAL FORMULATION FOR POORLY

BIO-AVAILABLE DRUG BASED ON MODULATION OF

THE ROLE OF PGP EFFLUX PUMP

DR.JIGAR VYAS

224 28-Jul-20 Hall 01 182650820001 Bhamtikar Krutik Kanti MRW404P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND CHARACTERIZATION OF GEL BASED

TOPICAL DRUG DELIVERY SYSTEM OF CLOXACILLIN

SODIUM

DR.KANTILAL B.

NARKHEDE

225 28-Jul-20 Hall 02 182540820007 RATHWA SURDAS KHUMANBHAI MRW404P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


PREPARATION AND EVALUATION OF CITRIC ACID

CROSS LINKED GELLAN GUM AND TAMARIND GUM

HYDROGEL FILM FOR TOPICAL DRUG DELIVERY OF

SULFACETAMIDE SODIUM

DR. ANAND DESHMUKH

226 28-Jul-20 Hall 02 182540820008 SINGH SHIKHAKUMARI VINOD MRW404P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF CYCLOSPORINE

TRANSFEROSOMAL GEL FOR TOPICAL DRUG DELIVERYDR. MANISH GOYANI

227 28-Jul-20 Hall 02 182610820002 PATEL JUHIBEN HARIKRUSHNABHAI MRW404P 20 261 MP Pharmaceutics OTHER (KINDLY SPECIFY)SOLUBILITY

ENHANCEMENT

FORMULATION AND DEVELOPMENT OF LIQUISOLID

TABLET OF POORLY SOLUBLE DRUGDR.JITENDRA PATEL

228 28-Jul-20 Hall 02 182650820003 NADA CHIRAG DHIRUBHAI MRW404P 20 265 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF SOLID LIPID

NANOPARTICLE OF ARTESUNATE AND MEFLOQUINE

HCL IN CAPSULE

MR.AJAY N.TALELE

229 28-Jul-20 Hall 02 182650820005 PATEL SAVANKUMAR PRAVINBHAI MRW404P 20 265 MP Pharmaceutics

CO PROCESSED, DC,


AT

FORMULATION ,DEVELOPMENT AND EVALUATION OF

ACEBROPHYLINE LOZENGES

DR. KANTILAL B.

NARKHEDE

230 28-Jul-20 Hall 02 182680820001 Basavaraj Savanoor MRW404P 20 268 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


EXPLORATION OF CLEARGEL TECHNOLOGY FOR

ENHANCED TOPICAL DELIVERY OF POORLY SOLUBLE

DRUG KETACONAZOLE

DR. DHIREN P SHAH

231 28-Jul-20 Hall 02 182680820002 CHAUDHARY PRIYAVANDA BIPINBHAI MRW404P 20 268 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


PREPARATION, OPTIMIZATION AND EVALUATION OF

ACYCLOVIR LOADED MICROEMULSION GEL FOR

TOPICAL DELIVERY

DR. DIXIT C MODI

of 27



Code

College_

Code

Branch_T




232 28-Jul-20 Hall 02 182680820003 MISTRY STUTIBEN NARESHKUMAR MRW404P 20 268 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF CHITOSAN

LOADED SALMON CALCITONIN NANOPARTICLES FOR

INTRANASAL DELIVERY AS ANTIRESORPTIVE THERAPY

FOR OSTEOPOROSIS

MRS. SONAL N SOLANKI

233 28-Jul-20 Hall 03 182390820004 HALPATI KARTIK THAKORBHAI MRW404P 20 239 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SPHERICAL AGGLOMERATES FOR SOLUBILITY

ENHANCEMENT OF THE ABIRATERONE ACETATE

USING QBD APPROACH

DR. HITESH DALVADI

234 28-Jul-20 Hall 03 182390820005 Joshi Chaitanya harshadkumar MRW404P 20 239 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND OPTIMIZATION OF ORALLY

DISINTEGRATING FILM OF CHLORPROMAZINE

HYDROCHLORIDE

MR. TULARAM BAROT

235 28-Jul-20 Hall 03 182390820006 MAURAYA RAJESHKUMAR KRUPASANKAR MRW404P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


INTRANASAL IN SITU GEL OF NANOPARTICULATED

POLYMERIC CARRIERS CONTAINING TEMOZOLOMIDE

DR. KOMAL PARMAR

236 28-Jul-20 Hall 03 182610820003 PATEL RIA NITINBHAI MRW404P 20 261 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND DEVELOPMENT OF

LULICONAZOLE MICROSPONGES FOR TOPICAL

DELIVERY SYSTEM USING QBD APPROACH

DR.CHAINESH SHAH

237 28-Jul-20 Hall 03 182650820006 SINHA SWATE ABHAY MRW404P 20 265 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION,DEVELOPMENT AND EVALUATION OF

AN IMMEDIATE RELEASE FILM COATED TABLETS OF

COLCHICINE

MR. AJAY N. TALELE

238 28-Jul-20 Hall 03 182680820004 PATEL DHRUVKUMAR NILESHBHAI MRW404P 20 268 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN,DEVELOPMENT AND CHARACTERIZATION OF

NANOPARTICLE LOADED TOPICAL GEL OF

APREMILAST.

MR. TEJAS J PATEL

239 28-Jul-20 Hall 03 182680820006 PATEL MOHINIBEN SHAILESHBHAI MRW404P 20 268 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



MUCOADHESIVE VAGINAL FILM OF OXYBUTYNIN

DR. JITENDRA SINGH

YADAV

240 28-Jul-20 Hall 03 182680820011 THAKOR HELI NILAYKUMAR MRW404P 20 268 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


NANOEMULSION BASED HYDROGEL OF

LULICONAZOLE : AN INNOVATIVE APPROACH FOR

TOPICAL DRUG DELIVERY

DR. RUMIT M SHAH

241 28-Jul-20 Hall 04 182390820008 PATEL DEVYANGI PRAKASH MRW404P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND EVALUATION OF IN-SITU GEL

FOR THE TREATMENT OF GASTRIC ULCERMR. TULARAM BAROT

242 28-Jul-20 Hall 04 182390820011 SOLANKI HARDIK MAHENDRASINH MRW404P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN AND CHARACTERIZATION OF IRINOTECAN

HYDROCHLORIDE LOADED COLON TARGETED BEADS

USING QBD APPROACH

DR. HITESH DALVADI

243 28-Jul-20 Hall 04 182390820012 YADAV SUNITA ACHCHHELAL MRW404P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


INJECTABLE IN-SITU IMPLANT DRUG DELIVERY FOR

ANTICANCER DRUG OF ABIRATERONE ACETATE

DR. HITESH DALVADI

244 28-Jul-20 Hall 04 182540820004 PANDYA PRIYANKA HARSHADBHAI MRW404P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)NANO COMPOSITE

SYSTEMS

DEVELOPMENT AND COMPARATIVE EVALUATION OF

ORGANICALLY MODIFIED NANO-COMPOSITE CLAY

BASED GELS FOR TREATMENT OF ARTHRITIS

MR. SUSHIL RAUT

245 28-Jul-20 Hall 04 182540820005 PATEL JINALKUMARI RAJESHBHAI MRW404P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)NANO COMPOSITE

SYSTEMS

FORMULATION AND CHARACTERIZATION OF NANO-

COMPOSITE CLAY-DRUG COMPLEXES FOR ORAL

DELIVERY OF IBUPROFEN

MR. SUSHIL RAUT

246 28-Jul-20 Hall 04 182540820009 TIWARI PRATIBHA AJAY MRW404P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)NANO COMPOSITE

SYSTEMS

DEVELOPMENT AND COMPARISON OF POLYMERIC

GELS CONTAINING NANO-COMPOSITE CLAY-DRUG

HYBRID SYSTEM FOR WOUND HEALING

MR. SUSHIL RAUT

247 28-Jul-20 Hall 04 182570820001 BHOJ HETAL DINESHBHAI MRW404P 20 257 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DESIGN AND DEVELOPMENT OF ZOLMITRIPTAN

LOADED NANOSTRACTURED LIPID CARRIERS (NLC)

FOR TREATMENT OF MIGRAINE

DR. ARA T. PATEL

248 28-Jul-20 Hall 05 182390820002 DHONDE BHOOMI YOGESHKUMAR MRW404P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,



EXEMESTANE LOADED LIPID-POLYMER HYBRID

NANOPARTICLES

DR. KOMAL PARMAR

of 27



Code

College_

Code

Branch_T




249 28-Jul-20 Hall 05 182390820003 HALPATI DIPESHBHAI GANPATBHAI MRW404P 20 239 MP Pharmaceutics MISCELANEOUSDEVELOPMENT, OPTIMIZATION AND EVALUATION OF

SPHERICAL AGGLOMERATES OF CLOZAPINEMR. TULARAM BAROT

250 28-Jul-20 Hall 05 182390820007 MAV URVI GOPALBHAI MRW404P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT, EVALUATION AND OPTIMIZATION OF

LIPID POLYMER HYBRID NANOPARTICLE BASED

INHALER CONTAINING PYRAZINAMIDE

DR. KOMAL PARMAR

251 28-Jul-20 Hall 05 182390820010 PATEL YASH VIJAYKUMAR MRW404P 20 239 MP Pharmaceutics MULTIPARTICULATE

DEVELOPMENT, CHARACTERIZATION AND

EVALUATION OF GEMCITABINE HYDROCHLORIDE

POLYMERIC MICROPARTICLES

DR. KOMAL PARMAR

252 28-Jul-20 Hall 05 182540820002 JADAV VISHALSING RAJESING MRW404P 20 254 MP PharmaceuticsNANO SUSPENSION/EMULSION,



NANOEMULSION FOR ORAL BIOAVAILABILITY

ENHANCEMENT OF LORATADINE

MR. SUSHIL RAUT

253 28-Jul-20 Hall 05 182680820005 PATEL HARSH DILIPKUMAR MRW404P 20 268 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN, DEVELOPMENT & EVALUATION OF MULTIPLE

UNIT FLOATING MINITABLETS OF CEFPODOXIME

PROXETIL

DR. JITENDRA SINGH

YADAV

254 28-Jul-20 Hall 05 182680820007 PATEL SARANGKUMAR MANOJBHAI MRW404P 20 268 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DESIGN, DEVELOPMENT AND CHARACTERIZATION OF

PROMETHAZINE HCL ORODISPERSIBLE TABLETDR. DHIREN P SHAH

255 28-Jul-20 Hall 05 182680820008 PATEL SEJALKUMARI BABUBHAI MRW404P 20 268 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DESIGN,DEVELOPMENT AND CHARACTERIZATION OF

FAST DISSOLVING ORAL FILM OF HALOPERIDOL.MR. TEJAS J PATEL

256 28-Jul-20 Hall 06 182390824001 ANCHAL SINGH MRW404P 24 239 MPPharmaceutical Quality


SIMULTANEOUS ESTIMATION OF FUSIDIC ACID AND

BECLOMETHASONE DIPROPIONATE BY

CHROMATOGRAPHIC METHOD IN THEIR


MRS.MADHURI HINGE

257 28-Jul-20 Hall 06 182390824002 Bhandari Truptiben Ramjibhai MRW404P 24 239 MPPharmaceutical Quality



INDICATING ANALYTICAL METHOD FOR

SIMULTANEOUS ESTIMATION OF TIMOLOL MALEATE

AND PILOCARPINE NITRATE IN COMBINED DOSAGE

FORM

DR. ALISHA PATEL

258 28-Jul-20 Hall 06 182390824003 DESAI ANAL PARIMAL MRW404P 24 239 MPPharmaceutical Quality


HPTLC AND STABILITY INDICATING RP-HPLC METHOD

DEVELOPMENT AND ITS VALIDATION FOR

ESTIMATION OF NADIFLOXACIN AND ADAPALENE IN

THEIR COMBINED TOPICAL FORMULATION

MRS. SHUCHI DESAI

259 28-Jul-20 Hall 06 182570824002 KHATRI VANITA AMARSINGH MRW404P 24 257 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL

METHOD FOR ESTIMATION OF ORCIPRENALINE

SULPHATE IN RAT PLASMA BY LC-MS/MS

OJAS PATEL

260 28-Jul-20 Hall 06 182650824001 AHIR HETVIBEN MANGUBHAI MRW404P 24 265 MPPharmaceutical Quality


"DEVELOPMENT AND VALIDATION OF STABILITY


OF EVOGLIPTIN TARTRATE IN PHARMACEUTICAL

DOSAGE FORM"

DR. D. P. DAMAHE

261 28-Jul-20 Hall 06 182650824007 PATEL HEMANGI ARVINDBHAI MRW404P 24 265 MPPharmaceutical Quality


BIOANALYTICAL METHOD DEVELOPMENT AND

VALIDATION FOR ESTIMATION OF AZILSARTAN IN

K3EDTA HUMAN PLASMA BY USING LC-ESI-MS-MS

DR. SACHIN B. NARKHEDE

262 28-Jul-20 Hall 06 182740824001 KARDANI MONALIBEN DILIPBHAI MRW404P 24 274 MPPharmaceutical Quality



METHODS FOR NEPAFENAC AND DEXAMETHASONE

IN COMBINATION

DR. H A RAJ

263 28-Jul-20 Hall 07 182390824004 DESAI SALONI SANJAYBHAI MRW404P 24 239 MPPharmaceutical Quality




HYDROCORTISONE ACETATE AND ATROPINE

SULPHATE IN MARKETED FORMULATION

DR. ALISHA PATEL

of 27



Code

College_

Code

Branch_T




264 28-Jul-20 Hall 07 182390824005 Dhodi Khyati Khalpa MRW404P 24 239 MPPharmaceutical Quality




LEVOFLOXACIN AND PREDNISOLONE ACETATE IN

SYNTHETIC MIXTURE

DR. ALISHA PATEL

265 28-Jul-20 Hall 07 182390824006 NAIK SHREYA NARESHBHAI MRW404P 24 239 MPPharmaceutical Quality




NADIFLOXACIN AND MOMETASONE FUROATE IN

SEMISOLID DOSAGE FORM.

MRS. SHUCHI DESAI

266 28-Jul-20 Hall 07 182390824007 PARMAR DRASTI MUKESHSINH MRW404P 24 239 MPPharmaceutical Quality




NEOSTIGMINE METHYLSULFATE AND

GLYCOPYRROLATE IN PHARMACEUTICAL DOSAGE

FORM

MRS. MADHURI HINGE

267 28-Jul-20 Hall 07 182570824001 HARMANI NIRAV JAYSUKHBHAI MRW404P 24 257 MPPharmaceutical Quality


METHOD

DEVELOPMENT



ESTIMATION OF DAROLUTAMIDE IN


DR. HARSHA U. PATEL

268 28-Jul-20 Hall 07 182570824003 MANOJKUMAR MRW404P 24 257 MPPharmaceutical Quality


ANNUAL PRODUCT QUALITY REVIEW (APQR) OF

TOPIRAMATE TABLETS USP 200 MGDR. HARSHA U. PATEL

269 28-Jul-20 Hall 07 182570824004 PANCHAL PUJA RAMESHBHAI MRW404P 24 257 MPPharmaceutical Quality


METHOD

DEVELOPMENT



ESTIMATION OF PEXIDARTINIB IN PHARMACEUTICAL

DOSAGE FORM

NEHA S. MOCHI

270 28-Jul-20 Hall 07 182740824002 KUSHWAHA RAMPYARI RAMGOPAL MRW404P 24 274 MPPharmaceutical Quality



METHODS FOR PARACETAMOL, IBUPROFEN AND

DEXAMETHASONE IN COMBINATION

DR. H A RAJ

271 28-Jul-20 Hall 08 182250824004 PATEL RIPALBEN DINESHBHAI MRW404P 24 225 MPPharmaceutical Quality




SAXAGLIPTIN, DAPAGLIFLOZIN AND METFORMIN

HYDROCHLORIDE IN TABLET

DR. DEEPA R. PATEL

272 28-Jul-20 Hall 08 182390824008 PATEL KHUSHBU BHARATBHAI MRW404P 24 239 MPPharmaceutical Quality



METHODS FOR CLOBETASOL PROPIONATE AND

CLOTRIMAZOLE IN CREAM

MRS. MEGHA SHAH

273 28-Jul-20 Hall 08 182390824009 PATEL PRACHIBEN JITENDRABHAI MRW404P 24 239 MPPharmaceutical Quality


SIMULTANEOUS ESTIMATION OF METFORMIN

HYDROCHLORIDE AND ALPHA LIPOIC ACID BY

CHROMATOGRAPHIC METHOD IN TABLET DOSAGE

FORM

MRS.MADHURI HINGE

274 28-Jul-20 Hall 08 182390824010 PATEL PREETI DILIP MRW404P 24 239 MPPharmaceutical Quality




ARIPIPRAZOLE AND ESCITALOPRAM OXALATE IN

SYNTHETIC MIXTURE

MRS.MADHURI HINGE

275 28-Jul-20 Hall 08 182390824011 PATEL PRIYABEN BIPINBHAI MRW404P 24 239 MPPharmaceutical Quality




HYDROCORTISONE ACETATE AND

CHLORAMPHENICOL IN EYE OINTMENT

MS. RAJVI MAHIDA

276 28-Jul-20 Hall 08 182650824004 GORI HAYA AMBALAL MRW404P 24 265 MPPharmaceutical Quality


METHOD DEVELOPMENT AND VALIDATION OF

DEXTROMETHORPHAN HYDROBROMIDE,

PHENYLEPHRINE HYDROCHLORIDE AND

CHLORPHENIRAMINE MALEATE IN TABLET DOSAGE

FORM BY HPTLC

DR. SHAILESH V LUHAR

277 28-Jul-20 Hall 08 182650824005 PAREKH KALGI DIVYESH MRW404P 24 265 MPPharmaceutical Quality



VALIDATION OF AMBROXOL HYDROCHLORIDE,

CHLORPHENIRAMINE MALEATE AND

DEXTROMETHORPHAN HYDROBROMIDE IN LIQUID

DOSAGE FORM BY RP-HPLC


of 27



Code

College_

Code

Branch_T




278 28-Jul-20 Hall 08 182650824006 PATEL DRASTI ANUPBHAI MRW404P 24 265 MPPharmaceutical Quality


SIMULTANEOUS ESTIMATION OF LOSARTAN

POTASSIUM, AMLODIPINE BESYLATE AND

CHLORTHALIDONE BY RP-HPLC METHOD


279 28-Jul-20 Hall 09 182250824006 PRAJAPATI HIMANI RAMESHBHAI MRW404P 24 225 MPPharmaceutical Quality




HALOBETASOL PROPIONATE AND TANZOROTENE IN

LOTION

DR. DEEPA R. PATEL

280 28-Jul-20 Hall 09 182390824012 PATEL RUPALI RAVINDRABHAI MRW404P 24 239 MPPharmaceutical Quality




OF FLUCONAZOLE AND ZINC PYRITHIONE IN THEIR

COMBINED MARKETED FORMULATION.

MRS. MEGHA SHAH

281 28-Jul-20 Hall 09 182390824013 Patel Trigal Jayeshbhai MRW404P 24 239 MPPharmaceutical Quality




CLOBETASOL PROPIONATE AND MICONAZOLE

NITRATE IN THEIR COMBINED DOSAGE FORM

MRS.MADHURI HINGE

282 28-Jul-20 Hall 09 182390824014 PRAJAPATI RITA BHAGVANDAS MRW404P 24 239 MPPharmaceutical Quality




HYDROCORTISONE ACETATE, BENZOIC ACID AND

SALICYLIC ACID IN THEIR PHARMACEUTICAL DOSAGE

FORM

MS.RAJVI MAHIDA

283 28-Jul-20 Hall 09 182390824015 ZALAK DESAI MRW404P 24 239 MPPharmaceutical Quality




SODIUM BENZOATE AND SODIUM PHENYLACETATE IN

SYNTHETIC MIXTURE

DR.ALISHA PATEL

284 28-Jul-20 Hall 09 182650824002 BAGDA NISHA DINESH MRW404P 24 265 MPPharmaceutical Quality



VALIDATION FOR ESTIMATION OF CILNIDIPINE AND

BISOPROLOL FUMARATE IN PHARMACEUTICAL

DOSAGE FORM BY HPTLC .

DR.D.P.DAMAHE

285 28-Jul-20 Hall 09 182650824003 DHIMMAR MAITRI NAVINCHANDRA MRW404P 24 265 MPPharmaceutical Quality



VALIDATION OF METRONIDAZOLE, FURAZOLIDONE

AND DICYCLOMINE HYDROCHLORIDE IN TABLET

DOSAGE FORM BY HPTLC

DR. SACHIN B. NARKHEDE

286 28-Jul-20 Hall 09 182650824008 PATEL KRINA SURYAKANT MRW404P 24 265 MPPharmaceutical Quality



VALIDATION OF TELMISARTAN AND BENIDIPINE

HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE

FORM BY HPTLC

DR. D. P. DAMAHE

287 29-Jul-20 Hall 01 182050828002 Nisha Choudhary MRW404P 28 205 MPPharmaceutical

Technology

CO PROCESSED, DC,


AT

IDENTIFICATION OF CRITICAL FACTORS INFLUENCING

THE INVITRO DISSOLUTION OF BICALUTAMIDE

TABLETS PREPARED USING MADG TECHNIQUE.

MS. DIPIKA CHAVDA

288 29-Jul-20 Hall 01 182120820001 AHIR TEJASKUMAR ASHOKBHAI MRW404P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY) COCRYSTALS

STUDIES IN FORMULATION AND EVALUATION OF

TADALAFIL COCRYSTALS TO IMPROVE DISSOLUTION

CHARACTERISTICS

DR. JAYANT R. CHAVDA

289 29-Jul-20 Hall 01 182120820002 BHALODIA KULDEEP KANTILAL MRW404P 20 212 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF SOLID SELF

MICRO EMULSIFYING DRUG DELIVERY SYSTEM OF

DASATINIB

MR. KALPESH A. PATEL

290 29-Jul-20 Hall 01 182120820003 CHAUHAN HARDIK ALPESHBHAI MRW404P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

FORMULATION AND EVALUATION OF AMOXICILLIN

TRIHYDRATE SOLID DISPERSION BY SPRAY DRYING

DR.CHETAN H.

BORKHATARIA

291 29-Jul-20 Hall 01 182120820006 KALASARIYA SANJAYKUMAR NATHABHAI MRW404P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

ENHANCEMENT OF SOLUBILITY AND IMPROVEMENT

OF PHYSICOCHEMICAL PROPERTIES BY FORMULATING

SPRAY DRIED SOLID DISPRSION OF DARUNAVIR

ETHANOLATE

DR.M. M. SONIWALA

of 27



Code

College_

Code

Branch_T




292 29-Jul-20 Hall 01 182120820007 MIR DEVALBEN BHANABHAI MRW404P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

AUGMENTATION OF PHYSICOCHEMICAL PROPERTIES

OF ETORICOXIB BY SPHERICAL AGGLOMERATIONDR.M. M. SONIWALA

293 29-Jul-20 Hall 01 182120820009 PATEL HEMAKSHIBEN DHIRAJLAL MRW404P 20 212 MP Pharmaceutics MULTIPARTICULATE

DESIGN, DEVELOPMENT AND OPTIMIZATION OF

PALIPERIDONE LOADED CHITOSAN NANOPARTICLES

FOR INTRANASAL DELIVERY

DR. SUNNY R. SHAH

294 29-Jul-20 Hall 01 182120820010 PATEL PARTHKUMAR HASMUKHBHAI MRW404P 20 212 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND EVALUATION OF PELLETS

CONTAINING RISPERIDONE AND TRIHEXYPHENIDYL

HCL.

DR.JAYDEEP.M.PATEL

295 29-Jul-20 Hall 02 182050828001 Asmita MRW404P 28 205 MPPharmaceutical

TechnologyMULTIPARTICULATE

DEVELOPMENT OF SUPERDISINTEGRATING

IMMEDIATE RELEASE FEBUXOSTAT PELLETS BY

INCORPORATING NOVEL EXCIPIENTS

DR. MUKESH C. GOHEL

296 29-Jul-20 Hall 02 182050828003 SANDEEP SATISHBHAI AGRAWAL MRW404P 28 205 MPPharmaceutical

TechnologyOTHER (KINDLY SPECIFY)

NOVEL

COMPRESSION

TECHNOLOGY

NOVEL TECHNIQUE FOR PREPARING METFORMIN

BILAYER TABLETDR. MUKESH C. GOHEL

297 29-Jul-20 Hall 02 182120820004 GANGANI USHABEN RAMESHBHAI MRW404P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY)SOLUBILITY

ENHANCEMENT

STUDY OF INVITRO MODULATORY EFFECT OF PH ON

HP-?-CD COMPLEX OF PIOGLITAZONE

HYDROCHLORIDE

DR. JAYANT R. CHAVDA

298 29-Jul-20 Hall 02 182120820005 GOSAI SHIVANGPARI MAHESHPARI MRW404P 20 212 MP PharmaceuticsNANO SUSPENSION/EMULSION,



CARVEDILOL DRY EMULSION USING SPRAY DRYING

TECHNIQUE

DR. DIPEN R. BHIMANI

299 29-Jul-20 Hall 02 182120820011 RANPARIYA FENIL MANSUKHBHAI MRW404P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY)DISSOLUTION

ENHANCEMENT

ENHANCEMENT OF DISSOLITUION PROPERTIES OF

CANDESARTAN CILEXETIL USING LIQUISOLID

TECHNIQUE

DR. RAMESH D. PARMAR

300 29-Jul-20 Hall 02 182120820012 SAKRIYA EKTA BHOLABHAI MRW404P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

FORMULATION,OPTIMIZATION AND EVALUATION OF

AMORPHOUS SOLID DISPERSION OF CEFUROXIME

AXETIL

MR. DHAVAL D. MORI

301 29-Jul-20 Hall 02 182120820013 Thoriya jay chandreshkumar MRW404P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF BUCCAL FILM

OF REPAGLINIDEDR. JALPA S. PAUN

302 29-Jul-20 Hall 03 182120824001 GOL DHRUVANSHIBEN ASHOKKUMAR MRW404P 24 212 MPPharmaceutical Quality




TADALAFIL AND MACITENTAN IN SYNTHETIC MIXTURE

USING RP-HPLC

DR. AMITKUMAR J. VYAS

303 29-Jul-20 Hall 03 182120824004 KishnaRam MRW404P 24 212 MPPharmaceutical Quality

AssuranceBABE


VALIDATION FOR ESTIMATION OF PHENYTOIN IN

HUMAN PLASMA (K3EDTA) BY USING LC-ESI-MS/MS.

DR. AJAY I. PATEL

304 29-Jul-20 Hall 03 182120824010 RAHULKUMAR LAKHABHAI MAKWANA MRW404P 24 212 MPPharmaceutical Quality



FOR SIMULTANEOUS ESTIMATION OF RANOLAZINE

AND METFORMIN HYDROCHLORIDE IN SYNTHETIC

MIXTURE

DR. ASHOK B. PATEL

305 29-Jul-20 Hall 03 182120824012 RAVAL DISHABEN HIMANSHUKUMAR MRW404P 24 212 MPPharmaceutical Quality


RP-HPLC METHOD DEVELOPMENT AND ITS


ROSUVASTATIN CALCIUM AND VITAMIN D3 IN TABLET

DOSAGE FORM.

DR. AMITKUMAR J. VYAS

306 29-Jul-20 Hall 03 182420824006 THAKAR RUCHIBEN ANILKUMAR MRW404P 24 242 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF DOLUTEGRAVIR AND

LAMIVUDINE IN TABLET

MS. CHARMY D. PANDYA

307 29-Jul-20 Hall 03 182690824003 KALOLA NENSI AMRUTLAL MRW404P 24 269 MPPharmaceutical Quality




CILNIDIPINE AND PROPRANOLOL IN COMBINED

DOSAGE FORM BY USING RP-HPLC METHOD.

KOMAL R. DHUDASHIA

308 29-Jul-20 Hall 03 182690824006 PAL ARCHANA HARIRAM MRW404P 24 269 MPPharmaceutical Quality




MIFEPRISTONE AND MISOPROSTOL IN ITâ€™S

COMBINED PHARMACEUTICAL DOSAGE FORM.

KOMAL R. DHUDASHIA

of 27



Code

College_

Code

Branch_T




309 29-Jul-20 Hall 03 182690824008 THESIYA SWATIBEN DHEERUBHAI MRW404P 24 269 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF A STABILITY-

INDICATING METHOD FOR THE SIMULTANEOUS

ESTIMATION OF AMBROXOL HYDROCHLORIDE AND

DOXYCYCLINE USING RP-HPLC

DHERENDRA KUMAR

TARAI

310 29-Jul-20 Hall 04 182120824003 JADAV HINABEN MENANDBHAI MRW404P 24 212 MPPharmaceutical Quality



INDICATING METHOD FOR SIMULTANEOUS

ESTIMATION OF ATORVASTATIN CALCIUM AND

VITAMIN D3 IN TABLET DOSAGE FORM BY RP-HPLC

DR. ASHOK B. PATEL

311 29-Jul-20 Hall 04 182120824005 PANDEY MEENAKSHI MANISHANKAR MRW404P 24 212 MPPharmaceutical Quality



FOR ESTIMATION OF ACOTIAMIDE HYDROCHLORIDE

TRIHYDRATE AND ITS RELATED SUBSTANCE

DR AMITKUMAR J. VYAS

312 29-Jul-20 Hall 04 182120824007 PATEL DHRUTI MAHESHKUMAR MRW404P 24 212 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF STATBILITY

INDICATING ANALYTICAL METHOD FOR ESTIMATION

OF CARIPRAZINE HYDROCHLORIDE AND ITS RELATED

SUBSTANCE BY HPLC

DR. NILESH K. PATEL

313 29-Jul-20 Hall 04 182610824002 Solanki Jaydipsinh Manharsinh MRW404P 24 261 MPPharmaceutical Quality

AssuranceDISSOLUTION STUDIES

DISSOLUTION METHOD DEVELOPMENT AND

VALIDATION OF THE TENELIGLIPTIN HBR HYDRATE

AND METFORMIN HCL SR IN COMBINED DOSAGE FOR

BY HPLC

MRS.PUJA VYAS

314 29-Jul-20 Hall 04 182690824004 Kanetiya Mansiben Mukeshbhai MRW404P 24 269 MPPharmaceutical Quality


RELATED

IMPURITIES (IN-

PROCESS

IMPURITIES)


METHOD FOR THE ESTIMATION OF TERIFLUNOMIDE

AND ITS RELATED IMPURITIES IN ITâ€™S ORAL SOLID

DOSAGE FORM.

KOMAL R. DHUDASHIA

315 29-Jul-20 Hall 04 182690824005 MINIYA PRIYANKABEN PARESHBHAI MRW404P 24 269 MPPharmaceutical Quality



INDICATING RP-HPLC METHOD FOR SIMULTANEOUS

ESTIMATION OF MIFEPRISTONE AND MISOPROSTOL

IN ITS ORAL SOLID DOSAGE FORM

DR SIBAJI SARKAR

316 29-Jul-20 Hall 04 182820824002 BANGIYA MINHAJ IKBAL MRW404P 24 282 MPPharmaceutical Quality




OF BEPOTASTINE HYDROCHLORIDE IN ITS BULK

DR. M.B.SHANKAR

317 29-Jul-20 Hall 04 182820824003 Thavrani Kajal Paresh MRW404P 24 282 MPPharmaceutical Quality



INDICATING ASSAY METHOD FOR ATAZANUVIR

SULPHATE IN BULK DRUG AND CAPSULE DOSAGE

FORM AND ITS APPLICATION IN DISSOLUTION BY RP-

HPLC.

DR. M.B.SHANKAR

318 29-Jul-20 Hall 05 182120824008 PATEL MAHINKUMAR PARESHBHAI MRW404P 24 212 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION FOR FIMASARTAN

POTASSIUM TRIHYDRATE AND ITS RELATED

SUBSTANCES BY HPLC

DR. NILESH K. PATEL

319 29-Jul-20 Hall 05 182120824011 RANA BHUMIKA HARISHBHAI MRW404P 24 212 MPPharmaceutical Quality


METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF RABEPRAZOLE

SODIUM AND MOSAPRIDE CITRATE IN TABLET

DOSAGE FORM BY UPLC

DR. NILESH K. PATEL

320 29-Jul-20 Hall 05 182120824014 VAGHASIYA EKTA HARSUKHBHAI MRW404P 24 212 MPPharmaceutical Quality



VALIDATION FOR ESTIMATION OF NITROGLYCERIN

AND ITS METABOLITES IN K3EDTA HUMAN PLASMA

USING LC-ESI-MS/MS

DR. ASHOK B. PATEL

321 29-Jul-20 Hall 05 182420824001 Bhayani Mital Arvindbhai MRW404P 24 242 MPPharmaceutical Quality

AssuranceOTHER (KINDLY SPECIFY) QBD CONCEPT

COMPARATIVE STUDY OF QBD IMPLEMENTATION

PERSPECTIVE IN USA, EUROPE, JAPAN AND INDIADR. ANKIT B. CHAUDHARY

of 27



Code

College_

Code

Branch_T




322 29-Jul-20 Hall 05 182420824002 DHARSANDIYA NIDHIBEN JENTILAL MRW404P 24 242 MPPharmaceutical Quality


METHOD

DEVELOPMENT

DEVELOPMENT & VALIDATION OF RP-HPLC METHOD

FOR ESTIMATION OF TENELIGLIPTIN AND ITS

IMPURITIES IN TABLET

DR. ANKIT B. CHAUDHARY

323 29-Jul-20 Hall 05 182420824004 Patel Chiragkumar Kamleshkumar MRW404P 24 242 MPPharmaceutical Quality


METHOD

DEVELOPMENT


METHOD FOR ESTIMATION OF DAPAGLIFLOZIN AND

ITS IMPURITIES DAPAGLIFLOZIN 3 AND

DAPAGLIFLOZIN 37

DR. NAVNEET F.

CHAUHAN

324 29-Jul-20 Hall 05 182420824005 PATEL RUCHITA RAJUBHAI MRW404P 24 242 MPPharmaceutical Quality


METHOD

DEVELOPMENT


METHOD FOR ESTIMATION OF LURASIDONE AND ITS

IMPURITIES LURASIDONE 1 AND LURASIDONE 8

DR. ANKIT B. CHAUDHARY

325 29-Jul-20 Hall 05 182690824007 SOLANKI HINALBEN KISHORBHAI MRW404P 24 269 MPPharmaceutical Quality



METHOD FOR VORTIOXETINE AND ITS IMPURITIES IN


DHERENDRA KUMAR

TARAI

326 29-Jul-20 Hall 05 172690824001 Savaliya Umang Yogeshkumar MRW403P 24 269 MPPharmaceutical

Quality AssuranceSTABILITY STUDIES


INDICATING RP-HPLC METHOD FOR

SIMULTANEOUS ESTIMATION OF LOTEPREDNOL

ETABONATE AND LEVOFLOXACIN IN BULK DRUG

DR SIBAJI SARKAR

327 29-Jul-20 Hall 06 182120824006 PATEL ASTHA JAMANBHAI MRW404P 24 212 MPPharmaceutical Quality




DEXTROMETHORPHAN HYDROBROMIDE AND

CHLORPHENIRAMINE MALEAT IN TABLET DOSAGE

FORM BY UPLC

DR. NILESH K. PATEL

328 29-Jul-20 Hall 06 182120824009 PRAJAPATI KRUPA BABUBHAI MRW404P 24 212 MPPharmaceutical Quality



METHOD FOR ESTIMATION OF GENOTOXIC

IMPURITIES IN HYDROXY CHLOROQUINE SULFATE

DRUG SUBSTANCE BY CHROMATOGRAPHY

DR. AJAY I. PATEL

329 29-Jul-20 Hall 06 182120824013 SHWETA GOSAI MRW404P 24 212 MPPharmaceutical Quality

AssuranceSOLUBILITY STUDIES



OF ELTROMBOPAG OLAMINE AND ITS RELATED

SUBSTANCE BY RP-HPLC

DR. AJAY I. PATEL

330 29-Jul-20 Hall 06 182250824008 RATHOD URVISHA RANJITBHAI MRW404P 24 225 MPPharmaceutical Quality




ALCAFTADINE AND KETOROLAC TROMETHAMINE IN

EYE DROP

DR. DEEPA R. PATEL

331 29-Jul-20 Hall 06 182420824003 MODI BIJAL JAYANTILAL MRW404P 24 242 MPPharmaceutical Quality

AssuranceREGULATORY AFFAIRS

COMPARATIVE STUDY OF REGULATORY GUIDELINE OF

BIOWAIVERS IN DIFFERENT REGULATORY MARKETMS. JIGNA T. PATEL

332 29-Jul-20 Hall 06 182690824001 Faldu Jay Maganlal MRW404P 24 269 MPPharmaceutical Quality



METHOD FOR LURASIDONE HYDROCHLORIDE AND ITS

IMPURITIES IN PHARMACEUTICAL DOSAGE FORM

DHERENDRA KUMAR

TARAI

333 29-Jul-20 Hall 06 182690824002 GAJERA BINAL ASHOKBHAI MRW404P 24 269 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF A STABILITY-

INDICATING RP-HPLC METHOD FOR ESTIMATION OF

SODIUM VALPROATE AND VALPROIC ACID IN

PRESENCE OF IMPURITY FROM A COMBINED ORAL

SOLID DOSAGE FORM

DR SIBAJI SARKAR

334 29-Jul-20 Hall 06 182690824009 VADGAMA TEJAS RAMNIKLAL MRW404P 24 269 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF STABILITY-


OF BEXAROTENE AND ITS IMPURITIES IN ORAL SOLID

DOSAGE FORM

DR SIBAJI SARKAR

335 29-Jul-20 Hall 07 182280822001 JADEJA SHWETABA BALBHADRASINH MRW404P 22 228 MPPharmaceutical

ChemistryOTHER (KINDLY SPECIFY) ANTI-TB AGENTS

DESIGN AND SYNTHESIS OF SOME NOVEL 1,3,4-

OXADIAZOLE ANALOGUES AS ANTI-TUBERCULAR

AGENTS

DR. DIPEN SUREJA

of 27



Code

College_

Code

Branch_T




336 29-Jul-20 Hall 07 182280822002 PATEL APEXA NAVNEETBHAI MRW404P 22 228 MPPharmaceutical

ChemistryOTHER (KINDLY SPECIFY) INFECTIOUS DISEASE

LEAD MODIFICATION STUDIES OF A SERIES OF

PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS

POTENTIAL ANTI-MYCOBACTERIAL AGENTS

DR. MAHESH T. CHHABRIA

337 29-Jul-20 Hall 07 182280822003 PATEL KISHAN RAMESHBHAI MRW404P 22 228 MPPharmaceutical

ChemistryOTHER (KINDLY SPECIFY)

MEDICINAL

CHEMISTRY-

ANTIFUNGAL

AGENTS

DESIGN, SYNTHESIS AND EVALUATION OF SOME

THIAZOLOPYRIMIDINE DERIVATIVE AS ANTIFUNGAL

AGENTS

PROF. MAHESH T.

CHHABRIA

338 29-Jul-20 Hall 07 182280822005 VAGHELA PUNIT VIJAYBHAI MRW404P 22 228 MPPharmaceutical


MEDICINAL

CHEMISTRY-ANTI-TB

AGENTS

DESIGN AND SYNTHESIS OF INDOLE-2-

CARBOXAMIDES AS POTENTIAL ANTI-TB AGENTSDR. TEJAS M. DHAMELIYA

339 29-Jul-20 Hall 07 182540822001 MIRZA SOHANABIBI RAFIK MRW404P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW DIAMINO PYRIMIDINE

DERIVATIVES AS ANTICANCER AGENTSDR. M. N. NOOLVI

340 29-Jul-20 Hall 07 182540822002 patel salman ismail MRW404P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW THIAZOLE DERIVATIVES AS

ANTICANCER AGENTSDR. M. N. NOOLVI

341 29-Jul-20 Hall 08 182020822001 KAPUPARA CHARVI ASHOKBHAI MRW404P 22 202 MPPharmaceutical


MEDICINAL

CHEMISTRY (ANTI

TUBERCULAR

AGENTS)

SYNTHESIS AND SCREENING OF BENZIMIDAZOLE

DERIVATIVES AS ANTI TUBERCULAR AGENTSDR. DINESH V. THAKKAR

342 29-Jul-20 Hall 08 182020822002 Patel Khushboo Hiteshbhai MRW404P 22 202 MPPharmaceutical


MEDICINAL

CHEMISTRY (ANTI

OBESITY AGENTS)

DESIGN, SYNTHESIS AND PANCREATIC LIPASE

INHIBITORY ACTIVITY OF NOVEL QUINAZOLINE

DERIVATIVES AS ANTI-OBESITY AGENTS

DR. VIPUL M. VAGHELA

343 29-Jul-20 Hall 08 182280822004 Pradhan Sanmey vikasbhai MRW404P 22 228 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTIDIABETICS)

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF

DERIVATIVES OF 2-AMINO THIOPHENE AS ANTI-

DIABETIC AGENTS

PROF. ANURADHA K.

GAJJAR

344 29-Jul-20 Hall 08 182540822003 RANA MAHIRAKHATUN RANJITSINH MRW404P 22 254 MPPharmaceutical


ANTI-ALZHEIMER

AGENTS

SYNTHESIS OF NEW FLAVONOL DERIVATIVES AS ANTI-

ALZHEIMER AGENTSDR. MORE UTTAM

345 29-Jul-20 Hall 08 182540822004 Vaja Mukesh MRW404P 22 254 MPPharmaceutical


ANTI-TUBERCULAR

AGENTS

SYNTHESIS OF NEW DIPHENYL ETHER DERIVATIVES AS

ANTI-TUBERCULAR AGENTSDR. MORE UTTAM

346 29-Jul-20 Hall 09 182280826001 FEFAR NIDHIBEN RAMESHBHAI MRW404P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: PREPARATION AND SCREENING OF

BOTANICAL FORMULATIONS WITH ANTI- ACNE

POTENTIAL. PART B: ISOLATION OF MAJOR

COUMARIN/S FROM PLEUROSPERMUM

ANGELICOIDES.

DR. MAMTA B SHAH

347 29-Jul-20 Hall 09 182280826002 JHALA SHAILJA BALBHADRASINH MRW404P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: ISOLATION OF BIOACTIVES FROM CRATAEVA

NURVALA. PART B: DEVELOPMENT AND EVALAUTION

OF MOSQUITO REPELLENT HERBAL FORMULATION.

DR. MAMTA B SHAH

348 29-Jul-20 Hall 09 182280826003 Soni Bhoomi Paraskumar MRW404P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: DEVELOPMENT AND ANALYSIS OF HERBAL

ANTI AGING SKIN CARE PRODUCTS PART B:

ISOLATION OF MAJOR BIOACTIVE FROM GARCINIA

INDICA.

DR. MAMTA B SHAH

349 29-Jul-20 Hall 09 182280826004TATMA SHAMBHUKUMAR

SHRIBALKRISHNADASMRW404P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: DEVELOPMENT OF HERBAL SUPPLEMENT FOR

DIABETES MITIGATION. PART B: METHOD

DEVELOPMENT FOR ISOLATION OF PHENOLIC

CONSTITUENT/S OF PSORALEA CORYLIFOLIA.

DR. MAMTA B SHAH

350 29-Jul-20 Hall 09 182600826001 VACHHANI TWINKLE MAHESHBHAI MRW404P 26 260 MP Pharmacognosy HERBAL RESEARCHPREPARATION AND EVALUATION OF POLY-HERBAL

FORMULATION FOR ARTHRITISMRS. PAYAL SUTHAR

351 30-Jul-20 Hall 01 182150827001 DESAI GRISHMABEN KETANBHAI MRW404P 27 215 MPPharmaceutical

Regulatory AffairsREGULATORY AFFAIRS

A STUDY ON REGULATORY REQUIREMENT FOR

REGISTRATION OF SIROLIMUS ELUTING CORONARY

STENT IN INDIA, EU AND TAIWAN

DR. RONAK DEDANIA

352 30-Jul-20 Hall 01 182880827002 BARAIYA KOMALBEN BHASKARRAY MRW404P 27 288 MPPharmaceutical


A COMPARISON OF REGULATORY REQUIREMENTS AS

PER USFDA & HEALTH CANADA FOR EYE DROPS AND

PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) FOR LIFITEGRAST OPTHALMIC

SOLUTION AS PER USFDA

DR. KASHYAP THUMMAR

of 27



Code

College_

Code

Branch_T




353 30-Jul-20 Hall 01 182880827005 KU SADHVI DHARAMNARAYAN TIWARI MRW404P 27 288 MPPharmaceutical


TO PROCESS, COMPILE AND VALIDATE ANDA

SUBMISSION IN E-CTD FORMAT FOR ORAL

SUSPENSION

MR. PRAVEENKUMAR

JAIN

354 30-Jul-20 Hall 01 182880827006 MAURYA PRITIKUMARI RADHESHYAM MRW404P 27 288 MPPharmaceutical


RIVASTIGMINE EXTENDED RELEASE FILM 4.6MG/24

HOURS - A GENERIC PRODUCT TO EXELON:

PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) FOR REGISTRATION IN USA

DR. R.H.PARIKH

355 30-Jul-20 Hall 01 182880827007 MEHTA HETAL MANISHKUMAR MRW404P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS OF FEBUXOSTAT

FILM COATED TABLET AS PER CENTRALISED

PROCEDURE OF EUROPEAN MEDICINE AGENCY (EMA)

DR. R.H.PARIKH

356 30-Jul-20 Hall 01 182880827014 ZALA TWINKLE DHANJIBHAI MRW404P 27 288 MPPharmaceutical


COMPARATIVE GLOBAL REGULATORY APPROACH

TOWARDS NITROSAMINE IMPURITIES AND TO

SUGGEST APPROPRIATE REGULATORY CONTROLS FOR

INDIA

MR.NIRAV CHOKSHI

357 30-Jul-20 Hall 02 182150827008 SINGH SHOBHA SATENDRA MRW404P 27 215 MPPharmaceutical


DOSSIER PREPARATION OF ROSUVASTATIN TABLET AS

PER REGISTRATION GUIDELINES OF RUSSIA AND

COMPARE WITH THE GUIDELINES OF EU.

DR. VINEET JAIN

358 30-Jul-20 Hall 02 182150827009 VANI NAMRATA SURESHCHANDRA MRW404P 27 215 MPPharmaceutical


DOSSIER PREPARATION FOR CLARITHROMYCIN

TABLET AS PER GUIDELINES OF UGANDA AND ITâ€™S

COMPARISON WITH GUIDELINES OF INDIA.

DR. RONAK DEDANIA

359 30-Jul-20 Hall 02 182880827001 ACHARYA SHARAD HARILAL MRW404P 27 288 MPPharmaceutical


TO PROCESS, COMPILE AND VALIDATE ANDA

SUBMISSION IN E-CTD FORMAT FOR EXTENDED

RELEASE TABLET WITH FILE TAGGING IN CLINICAL

PART

MR. PRAVEENKUMAR

JAIN

360 30-Jul-20 Hall 02 182880827003 DAVE KEYUR PIYUSHKUMAR MRW404P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS AS PER USFDA

FOR INTRAVENOUS COMBINATION OF CEFTOLOZANE

SULFATE & TAZOBACTAM SODIUM - A GENERIC

PRODUCT TO ZERBAXA

DR. R.H.PARIKH

361 30-Jul-20 Hall 02 182880827004 KHAMAR VIDHI VINAYBHAI MRW404P 27 288 MPPharmaceutical


ARFORMOTEROL TARTRATE INHALATION SOLUTION :

PREPARATION OF ABBREVIATED NEW DRUG

APPLICATION (ANDA) AS PER USFDA

DR. VISHWAS RANPARIYA

362 30-Jul-20 Hall 02 182880827009 Panchal kinjal pankajbhai MRW404P 27 288 MPPharmaceutical


PREPARATION OF ACTD DOSSIER FOR COMBINATION

OF ARTEMETHER AND LUMEFANTRINE AS A POWDER

FOR ORAL SUSPENSION AND A STUDY ON

IMPLEMENTATION OF VARIATION AS PER ASEAN

GUIDELINE

DR. KASHYAP THUMMAR

363 30-Jul-20 Hall 02 182880827010 PAREKH ISHANI HITESHKUMAR MRW404P 27 288 MPPharmaceutical


A STUDY ON ABBREVIATED NEW DRUG APPLICATION

(ANDA) REGISTRATION PROCESS FOR CANAGLIFLOZIN

TABLET AS PER USFDA.

MS. DIPA MEHTA

364 30-Jul-20 Hall 03 182150827004 PATEL NILIMA DHIRUBHAI MRW404P 27 215 MPPharmaceutical


TO PREPARE A DOSSIER CONTAINING LEVOFLOXACIN

TABLET FOR REGISTRATION IN MYANMAR WITH

RESPECT TO CMC SECTION AND ITâ€™S COMPARISON

WITH USA.

DR. VINEET JAIN

365 30-Jul-20 Hall 03 182150827006 SHAH KINJAL VINAY MRW404P 27 215 MPPharmaceutical


REGULATORY REQUIREMENT FOR DOSSIER

SUBMISSION FOR DICLOFENAC POTASSIUM AND

LOPERAMIDE IN NIGERIA AND KENYA.

DR. RONAK DEDANIA

366 30-Jul-20 Hall 03 182150827007 SHIRSATH ARCHANA SATISH MRW404P 27 215 MPPharmaceutical


CURRENT REGULATORY REQUIREMENT FOR

REGISTRATION OF ONCOLOGICAL PRODUCT IN

MYANMAR, INDIA AND NEPAL

DR. VINEET JAIN

of 27



Code

College_

Code

Branch_T




367 30-Jul-20 Hall 03 182880827008 MOURYA MAMTASHANTI SHAMBHUNATH MRW404P 27 288 MPPharmaceutical


A COMPARISON OF REGULATORY REQUIREMENTS AS

PER USA & SOUTH AFRICA FOR POWDER FOR

INJECTION AND PREPARATION OF DRAFT

ABBREVIATED NEW DRUG APPLICATION (ANDA) FOR

ENFUVIRTIDE POWDER FOR INJECTION AS PER USFDA

DR.KASHYAP THUMMAR

368 30-Jul-20 Hall 03 182880827011 PATEL NIDHI HASMUKHBHAI MRW404P 27 288 MPPharmaceutical


A COMPARATIVE STUDY OF REGULATORY

REQUIREMENTS IN INDIA & USA FOR MEDICAL

DEVICES AND A STUDY OF PRODUCT APPROVAL

PROCESS FOR IN-VITRO DIAGNOSTICS (IVDS) AS PER

INDIAN REGULATORY SYSTEM

DR. KASHYAP THUMMAR

369 30-Jul-20 Hall 03 182880827012 revati kabariya MRW404P 27 288 MPPharmaceutical


A STUDY ON BIOSIMILAR PRODUCT REGISTRATION

PROCESS FOR PERTUZUMAB INJECTION THROUGH

CENTRALISED PROCEDURE AS PER EMA

MS. DIPA MEHTA

370 30-Jul-20 Hall 03 182880827013 ROHIT KUMAR MRW404P 27 288 MPPharmaceutical


MODEL DOSSIER FOR WHO PREQUALIFICATION AND

IMPLEMENTATION OF VARIATION AS PER WHO

GUIDELINE

MR.NIRAV CHOKSHI

371 30-Jul-20 Hall 04 182820829002 PANDYA SHIVANGI BIPINCHANDRA MRW404P 29 282 MP Clinical Pharmacy CLINICAL STUDY (CVS)A COMPARATIVE STUDY OF NIFEDIPINE AND

LABETALOL IN PREGNANCY INDUCED HYPERTENSIONDR. HETAL D. SOLANKI

372 30-Jul-20 Hall 04 182820829003 PATEL PRACHI SHAILESHKUMAR MRW404P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY) SKIN INFECTIONSTO STUDY THE AWARENESS OF SKIN INFECTION

AMONG ADULTS AT TERTIARY CARE CENTRE, ANAND.DR. HETAL D. SOLANKI

373 30-Jul-20 Hall 04 182820829004 CHAUDHARI LOKITABEN ANILKUMAR MRW404P 29 282 MP Clinical PharmacyPHARMACY PRACTICE &

CLINICAL STUDY (DIABETES)

TO STUDY THE BENEFICIARY EFFECT OF METFORMIN +

SITAGLIPTIN COMBINATION VS METFORMIN ALONE

IN TYPE 2 DIABETIC PATIENTS.

DR. HETAL D. SOLANKI

374 30-Jul-20 Hall 04 182820829005 KARAN KALPESH BAJANIYA MRW404P 29 282 MP Clinical Pharmacy BABE STUDY

TO ESTABLISH BIOEQUIVALENCE OF SODIUM

VALPROATE ORAL SOLUTION IN HEALTHY, ADULT,

MALE HUMAN SUBJECTS UNDER FASTING CONDITION

DR. HETAL D. SOLANKI

375 30-Jul-20 Hall 04 182820829006 RATHOD TARUN JETHABHAI MRW404P 29 282 MP Clinical Pharmacy BABE STUDY

TO ESTABLISH BIOEQUIVALENCE OF

URSODEOXYCHOLIC ACID CAPSULE IN HEALTHY,

ADULT, MALE HUMAN SUBJECTS UNDER FASTING

CONDITION

DR. JIGNESH SHAH

376 30-Jul-20 Hall 04 182820829007 SHUKLA BHARGAV DINESHCHANDRA MRW404P 29 282 MP Clinical Pharmacy BABE STUDY

TO ESTABLISH BIOEQUIVALENCE OF GLIPIZIDE

EXTENDED RELEASE TABLET IN HEALTHY, ADULT,

MALE HUMAN SUBJECTS UNDER FED CONDITION

DR. JIGNESH SHAH

377 30-Jul-20 Hall 04 182820829008 VANDANA AMIT SHARMA MRW404P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)PHARMACOVIGILAN

CE

A STUDY ON CLINICAL PATTERN OF ADVERSE DRUG

REACTIONS TO THE DRUGS USED FOR HYPERTENSION

AND ASSESMENT OF MEDICATION KNOWLEDGE IN

SUCH PATIENTS.

DR. JIGNESH G. SHAH

378 30-Jul-20 Hall 05 182050825003 CHANDEL ATULSINGH JAYNARAYANSINGH MRW404P 25 205 MP Pharmacology CVS DISORDER

EVALUATION OF NLRP3 INFLAMMASOME INHIBITOR

IN EXPERIMENTALLY INDUCED CARDIAC FIBROSIS IN

UNINEPHRECTOMIZED RATS

DR. TEJAL GANDHI

379 30-Jul-20 Hall 05 182050825004 GAJERA HARSHKUMAR BHARATBHAI MRW404P 25 205 MP Pharmacology CVS DISORDER

EVALUATION OF PROTECTIVE EFFECT OF SNAIL-1

INHIBITOR IN CARDIAC FIBROSIS IN EXPERIMENTAL

RATS

DR. TEJAL GANDHI

380 30-Jul-20 Hall 05 182050825005 KAZI ASFIYA JAVIDALI MRW404P 25 205 MP Pharmacology CVS DISORDER

EVALUATION OF ANTHRAQUINONE RICH FRACTION

OF RHUBARB IN CARDIAC FIBROSIS IN EXPERIMENTAL

RATS

DR. SARIKA JOHARI

381 30-Jul-20 Hall 05 182120825001 KANABAR KRINA BHUPATBHAI MRW404P 25 212 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

TOPICAL AND SYSTEMIC USE OF AZADIRACHTA

INDICA LEAVES USING IN-VITRO AND IN-VIVO ASSAYSDR. DEVANG B. SHETH

of 27



Code

College_

Code

Branch_T




382 30-Jul-20 Hall 05 182120825002 KHILJI RUKHSHAR BANU MRW404P 25 212 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTI-DIABETIC ACTIVITY OF ECO

ENSULIN IN EXPERIMENTALLY INDUCED DIABETES IN

RATS

DR. RAVI A. MANEK

383 30-Jul-20 Hall 05 182130825001 DHAMANE DIVYANSHI AVINASH MRW404P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF SAXAGLIPTIN 2.5 MG

AND METFORMIN 1000 MG FILM COATED TABLETS IN

FED CONDITIONS

DR. DIGVIJAYSINH G.

RANA

384 30-Jul-20 Hall 05 182130825002GHODASARA DENISHKUMAR

DINESHKUMARMRW404P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF FEBUXOSTAT FILM

COATED TABLETS 80 MG IN FASTING CONDITIONS

DR. DIGVIJAYSINH G.

RANA

385 30-Jul-20 Hall 05 182280825002 HIMIKA HASMUKHBHAI RATHI MRW404P 25 228 MP Pharmacology CNS DISORDER

EVALUATION OF DOPAMINE RECEPTOR

MODULATORS ON MORPHINE TOLERANCE AND

ADDICTION IN MICE

DR. MEHUL R.

CHORAWALA

386 30-Jul-20 Hall 06 182120825003 KRITIKA RAINA MRW404P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO-

INFLAMMATORY

EVALUATION OF ANTI-ARTHRITIC ACTIVITY OF

PETROSELINUM CRISPUM LEAVES EXTRACT BY

FREUNDS ADJUVANT INDUCED ARTHRITIS IN RATS

DR. RAVI A. MANEK

387 30-Jul-20 Hall 06 182120825004 MAJITHIA BRINDA RAJESHBHAI MRW404P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO

MODULATORY`

PHARMACOLOGICAL EVALUATION OF

IMMUNOMODULATORY AND ANTI-INFLAMMATORY

ACTIVITY OF CURCUMIN C3 COMPLEX CAPSULES IN

RATS.

DR. RAVI A. MANEK

388 30-Jul-20 Hall 06 182120825007 PATEL VRUTTI THAKORBHAI MRW404P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO-

INFLAMMATORY

EVALUATION OF EFFECT OF ETHANOLIC EXTRACT OF

FAGONIA CRETICA L. PLANT AGAINST

EXPERIMENTALLY INDUCED ULCERATIVE COLITIS IN

MICE

DR. DEVANG B. SHETH

389 30-Jul-20 Hall 06 182120825008 sorathiya kirti dineshbhai MRW404P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO-

INFLAMMATORY

EVALUATION OF EFFECT OF METHANOLIC EXTRACT

OF MEDICAGO SATIVA L. SPROUTS ON CHEMICAL

INDUCED ULCERATIVE COLITIS IN MICE

DR. JIGNESH I. PATEL

390 30-Jul-20 Hall 06 182280825003 PANCHAL VIDHI NATVARLAL MRW404P 25 228 MP Pharmacology CVS DISORDER

EVALUATION OF PROTECTIVE EFFECTS OF PHLORIZIN

IN EXPERIMENTALLY INDUCED MYOCARDIAL I/R

INJURY.

DR. ANITA A. MEHTA

391 30-Jul-20 Hall 06 182280825007 PUROHIT SWETA HAREH MRW404P 25 228 MP Pharmacology CVS DISORDEREVALUATION OF CARDIOPROTECTIVE EFFECTS OF

CILOSTAZOL IN I/R INJURY IN ISOLATED RAT HEARTDR. ANITA A. MEHTA

392 30-Jul-20 Hall 06 182280825009 Trivedi Mansi Vinod kumar MRW404P 25 228 MP Pharmacology CVS DISORDER

EVALUATION OF CARDIOPROTECTIVE ACTIVITY OF

METFORMIN, RESVERATROL AND BERBERINE ALONE

AND IN COMBINATION IN ISOPROTERENOL INDUCED

HEART FAILURE IN RATS

DR. GAURANG B. SHAH

393 30-Jul-20 Hall 06 182390825008 TAILOR SHIVANGI ISHWARBHAI MRW404P 25 239 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EFFECT OF POLYHERBAL COMBINATION IN

OVARIECTOMIZED RAT MODEL WITH REFERENCE TO

POSTMENOPAUSAL SYNDROME

MR. MITTAL DALAL

394 30-Jul-20 Hall 07 182130825003 sardhara shivani rajendrakumar MRW404P 25 213 MP Pharmacology OTHER (KINDLY SPECIFY)REPRODUCTIVE

DISEASES

AN OBSERVATIONAL STUDY OF DRUG UTILIZATION IN

GYNAECOLOGICAL INFECTIONSDR. DEEPTI K. JANI

395 30-Jul-20 Hall 07 182280825005 Patel Krupa Dineshkumar MRW404P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY) LIVER DISEASEEFFICACY STUDY OF CAMEL MILK AND EPALRESTAT

AGAINST HEPATOTOXICITY IN RATS

DR. MUSTAKIM M.

MANSURI

396 30-Jul-20 Hall 07 182280825008 TRIPATHI ASHUTOSH RAMASHANKER MRW404P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY)AUTO IMMUNE

DISORDER

ASSESSMENT OF SEROTONINS ROLE IN CFA INDUCED

RHEUMATOID ARTHRITIS IN RATS

DR. MUSTAKIM M.

MANSURI

397 30-Jul-20 Hall 07 182280825010 VAGHELA KIRAN BHARATKUMAR MRW404P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY) LIVER DISEASE

COMPARATIVE EFFICACY STUDY OF LIVE AND HEAT

KILLED SACCHAROMYCES CEREVISIAE IN

COMBINATION WITH SODIUM SELENATE IN CCL4

INDUCED LIVER FIBROSIS IN RAT

DR. GAURANG B. SHAH

398 30-Jul-20 Hall 07 182390825001 DAVDA BHAKTI KAILESH MRW404P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) PCOS

EFFECT OF BAUHINIA PURPUREA BARK EXTRACT AND

ANETHUM GRAVEOLENS FRUIT EXTRACT ON

EXPERIMENTALLY INDUCED POLYCYSTIC OVARY

SYNDROME IN RATS

DR. ARINDAM PAUL

of 27



Code

College_

Code

Branch_T




399 30-Jul-20 Hall 07 182390825002 JAINEE DAXESH VASHI MRW404P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) BPH

EFFECT OF POLYHERBAL FORMULATION AGAINST

EXPERIMENTALLY INDUCED MODELS OF BENIGN

PROSTATIC HYPERPLASIA IN RATS

MR. MITTAL DALAL

400 30-Jul-20 Hall 07 182390825007 SALUNKE SNEHAL SHRIKANT MRW404P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) ANTI-HEMORRHOID

PHARMACOLOGICAL EVALUATION OF ANTI-

HEMORRHOIDAL POTENTIAL OF POLYHERBAL

FORMULATIONS AGAINST CROTON OIL INDUCED

MODEL IN RATS

DR. ARINDAM PAUL

401 30-Jul-20 Hall 07 182390825009 TANDEL DIVYA JITENDRA MRW404P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) ARTHRITIS

EFFECT OF DIOSCOREA HISPIDA DENNST. TUBER ON

EXPERIMENTALLY INDUCED RHEUMATOID ARTHRITIS

AND GOUT IN RATS

DR. ARINDAM PAUL

402 30-Jul-20 Hall 08 182050825001 AGHERA CHIRAGKUMAR RASIKLAL MRW404P 25 205 MP Pharmacology TOXICITY STUDYSYSTEMATIC TOXICOLOGICAL EVALUATION OF

NATURAL FLAVONOID QUERCETIN IN RODENTSDR. SARIKA JOHARI

403 30-Jul-20 Hall 08 182050825007 RANA KHYATI MUKESHBHAI MRW404P 25 205 MP Pharmacology CVS DISORDER

EVALUATION OF CARDIOPROTECTIVE EFFECT OF

RANOLAZINE IN HIGH FAT DIET AND

STREPTOZOTOCIN INDUCED DIABETIC

CARDIOMYOPATHY

DR. TEJAL GANDHI

404 30-Jul-20 Hall 08 182050825008 SAIYED FALAKAARA HASHMATALI MRW404P 25 205 MP Pharmacology CVS DISORDERSTUDY OF CARDIOPROTECTIVE EFFECT OF PRASUGREL

IN MYOCARDIAL ISCHEMIA/REPERFUSION INJURYDR. TEJAL GANDHI

405 30-Jul-20 Hall 08 182050825010 Thakkar Brijesh Jayendra MRW404P 25 205 MP Pharmacology CVS DISORDER

EFFECT OF PPAR ?/G DUAL AGONIST IN

STREPTOZOTOCIN INDUCED DIABETIC

CARDIOMYOPATHY IN RATS

DR. TEJAL GANDHI

406 30-Jul-20 Hall 08 182390825004 MAITRI RAJESH KALAN MRW404P 25 239 MP Pharmacology TOXICITY STUDYSUBCHRONIC TOXICITY STUDY OF T-AYU-HMâ„¢

PREMIUM : A HERBOMINERAL FORMULATIONDR. ANKIT MERAI

407 30-Jul-20 Hall 08 182680825001 CHAUDHARI FALGUNIKUMARI SATISHBHAI MRW404P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY)

ANALGESIC AND

ANTI-

INFLAMMATORY

EVALUATION OF ANALGESIC AND ANTI-

INFLAMMATORY ACTIVITIES OF MANILKARA

HEXANDRA (ROXB) LEAVES IN WISTAR RATS

DR. VIJAY B. LAMBOLE

408 30-Jul-20 Hall 08 182680825002 PATEL CHARMIBEN JAYANTIBHAI MRW404P 25 268 MP Pharmacology RENAL DISORDERS

EVALUATION OF ANTI-UROLITHIATIC POTENTIAL OF

MANILKARA HEXANDRA (ROXB) LEAVES IN WISTAR

RATS

DR. VIJAY B. LAMBOLE

409 30-Jul-20 Hall 08 182680825003 PRAJAPATI ANKITKUMAR BHARATBHAI MRW404P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY) JOINTS

EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF

ABIES WEBBIANA LINDL. LEAVES ON EXPERIMENTALLY

INDUCED ARTHRITIS MODEL IN RATS

MR. VIPULKUMAR GAJERA

410 30-Jul-20 Hall 09 182050825002 Chanchal Yadav MRW404P 25 205 MP Pharmacology RENAL DISORDERSEVALUATION OF ANTI-UROLITHIATIC EFFECT OF

HERBAL FORMULATIONS IN EXPERIMENTAL RATSDR. TEJAL GANDHI

411 30-Jul-20 Hall 09 182050825009 SANCHANIYA DIVYA ARVINDBHAI MRW404P 25 205 MP Pharmacology RENAL DISORDERS

EFFECT OF SAPONIN AND FLAVONOID RICH EXTRACTS

OF BRYOPHYLLUM PINNATUM ON CRYSTAL

DEPOSITION IN EXPERIMENTAL UROLITHIASIS

DR. TEJAL GANDHI

412 30-Jul-20 Hall 09 182280825001 Chettiar Poojashree Boopathyraj MRW404P 25 228 MP Pharmacology CANCER

EVALUATION OF ANTICANCER MODULATING

EFFICACY OF ACANTHUS ILICIFOLIUS AND MUSA

PARADISIACA AND MODULATION OF DOCETAXEL

EFFICACY ON PROSTATE CANCER CELLS

DR. SUNITA GOSWAMI

413 30-Jul-20 Hall 09 182280825006 PATEL VISHWABEN MUKESHBHAI MRW404P 25 228 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUTION OF ANTI FIBROTIC EFFECT OF

OMEPRAZOLE AND D- PENICILLAMINE IN BLEOMYCIN

INDUCED LUNG FIBROSIS IN MICE

DR. GAURANG B. SHAH

414 30-Jul-20 Hall 09 182390825003 Lakhani Ruchita Sahbudin MRW404P 25 239 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY

DISORDER OR DISEASE)

EVALUATION OF LAXATIVE EFFECT OF VASULAX - A

POLYHERBAL FORMULATION.DR. ARINDAM PAUL

415 30-Jul-20 Hall 09 182390825005 Megha Menon MRW404P 25 239 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY


CYTOPROTECTIVE EFFECT OF IN-SITU GEL

CONTAINING TANNINS AGAINST EXPERIMENTALLY

INDUCED PEPTIC ULCER IN RATS

MR. MITTAL DALAL

416 30-Jul-20 Hall 09 182390825006 MULLA KAYNAT MUSTAQ MRW404P 25 239 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY


EFFECT OF POLYHERBAL FORMULATION, ACIDEZ,

AGAINST EXPERIMENTALLY INDUCED GASTRIC ULCER

IN RATS

DR. ANKIT MERAI

of 27

gujarat technological university student list for m.pharm ... · 40 23-jul-20 hall 06 182060824007...

Documents